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?Abstract 
The interactions between a host and his/her microbiota have co-evolved over time 
and they exert profound effects on each other. Intestinal microbiota has been linked 
with a number of diseases, such as irritable bowel syndrome; it is considered to be a 
major etiopathological factor since it can alter intestinal homeostasis. However, the 
role of intestinal microbiota, especially commensals, is unclear in celiac disease. To 
date, most efforts for detecting potential microbial changes affected by celiac 
disease have focused on adult individuals and have examined fecal materials, 
although it is known that early life is the critical period for the microbiota to 
colonize and establish their niche in the human intestine.  At this time in healthy 
individuals, there is continuing cross-talk with the host e.g. via the immune system, 
leading to the establishment of homeostasis in both metabolic and immunological 
programming.  Since the intestinal epithelium is the main interface for host-
microbe interactions, the role of mucosa-associated microbiota may be distinct 
from that of fecal microbiota, but both the normal fluctuations in intestinal 
microbiota and the composition of duodenal mucosa-associated microbiota are still 
not fully clarified.  
The aims of thesis were to characterize the development and stability of intestinal 
microbiota in healthy young children and to compare the microbial features 
between children and adults. Furthermore, the aim was to investigate host-microbe 
interactions in celiac disease by studying duodenal mucosa-associated microbial 
signatures and mucosal gene expression in healthy children and their counterparts 
with celiac disease. The microbiota profiles were characterized by using the human 
intestinal tract chip (HITChip), which is a bacterial phylogenetic microarray. The 
amounts of Bifidobacterium spp. in children and adults were verified with real time 
qPCR. The levels of mucosal gene expressions were quantified with reverse 
transcriptase quantitative PCR. 
The results showed that intestinal microbiota is not fully matured at the age of five 
in children. A common core microbiota, including several butyrate-producing 
bacteria, was identified in children and it was developing towards core microbiota 
found in adults. The different progression pattern of major bacterial taxa may 
reflect the physiological development steps in children. Moreover, differences were 
observed between healthy- and celiac disease- associated microbial signatures. The 
differences may reflect changes in epithelial integrity associated with the disease. 
On the other hand, the studies on both microbiota and mucosal gene expression 
indicated that the persistently enhanced Th1 type immune responsiveness in 
subjects with celiac disease after treating with gluten-free diet might result from the 
increased expression of TLR9, which recognizes unmethylated CpG motifs in 
bacterial DNA via the direct stimulation of immune cells and/or intestinal epithelial 
cells. 
The results of this thesis project suggest that specific symbiotic and dysbiotic 
microbial signatures may provide potential functional diagnostic or therapeutic 
targets for promoting healthy/natural microbiota development. Long-term studies 
in a controlled environment with an adequate number of participants will be 
necessary to decode the disturbed microbial signatures. These trials should be 
combined with systematic pathological surveillance to reveal how the changes in the 
microbiota influence the onset of disease. 
 
?1.?INTRODUCTION 
In the past 50 years, human life-styles and diet in Western countries have 
undergone a huge transformation. Urbanization, industrialization and medical 
practices, such as the use of antibiotics, have led to excessively hygienic living 
conditions (Campbell 2014; Haahtela et al. 2013). The current hygiene hypothesis 
states that early life exposure to microorganisms, such as commensals, is crucial for 
immunological and metabolic programming, and that if this exposure is inadequate 
or proceeds in an aberrant manner, it can contribute to the appearance of the 
immunoregulatory defects that underlie the increased prevalence of chronic 
inflammatory disorders now so common in the developed countries (Isolauri et al. 
2009). Examples of disorders linked to the hygienic hypothesis are allergies and 
autoimmune diseases, such as type 1 diabetes (T1D), Celiac disease (CeD) and 
inflammatory bowel disease (IBD), particularly Crohn’s disease (Campbell 2014; 
Prescott 2013). Among these diseases, chronic intestinal mucosal inflammation is 
the main histological and clinical manifestation of CeD and IBD, as either a cause or 
a consequence of disrupted intestinal (or gut) homeostasis, i.e. changes in the host-
microbe interactions. This palette of symptoms refers to dys-regulated immunity, 
impaired physical barrier function or microbial dysbiosis.  
 
 
Figure 1. Schematic representation of different factors in health and diseases. 
 
Intestinal barrier, including both physical and immunological barrier, has evolved 
to prevent invasion of endogenous or exogenous irritants from intestinal lumen to 
the host, such as microbes and chemical toxicants (Bischoff et al. 2014) (Fig. 1). The 
co-evolution of gastrointestinal (GI) microbes and their mammalian hosts can 
influence which microbial species and how many of them are able to colonise within 
the host and this then modulates the functions of intestinal barriers of the host (Fig. 
1). Evolutionary interactions with microbes are considered as key contributors to 
intestinal homeostasis which is essential for the host to remain healthy (Sommer et 
al. 2014). These beneficial interactions are dynamic processes during the 
development of host physiology, initiated immediately when the first microbes 
colonize the host intestine (Rautava, Luoto, et al. 2012). Although these interactions 
are active constantly throughout the whole life span, early life in childhood has been 
postulated to be crucial for the shaping of both the host metabolism and the 
immune system, introducing profound short and long term effects on host health 
(Sommer and Bäckhed 2013; Rautava, Luoto, et al. 2012).  
Celiac disease (CeD) is an autoimmune disorder, which often starts during 
childhood and lasts for the individual’s whole life. The disease is triggered by 
dietary gluten and characterized by inflammation of the small intestine. The 
pathogenesis of the disease is thought to be multifactorial involving the intolerance 
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?of gluten via complex interactions between the host’s genetic predisposition, a 
microbial dysbiosis and environmental factors (Fig. 1).  In particular, commensal 
bacteria may play a crucial role in celiac disease as they can maintain the intestinal 
barrier and modulate many immunological functions (Cinova et al. 2011; Galipeau 
et al. 2014; Lindfors et al. 2008).  
In order to obtain a better understanding of the complex host-microbe interactions 
in pediatric celiac disease, it is crucial to characterize the microbiota in childhood 
and understand whether the disease state can be related to changes in certain 
microbes. With the development of high-throughput molecular profiling methods, 
it is now possible to undertake a holistic characterization of intestinal microbiota in 
both healthy subjects and CeD patients. The aims of thesis were to characterize the 
development of intestinal microbiota in healthy children and to investigate host-
microbe interactions in celiac disease.  
 
2.?LITERATURE REVIEW 
2.1? Host-microbe interactions 
The human GI-tract is composed of the stomach, small intestine and large intestine. 
Together with other digestive organs, such as liver and pancreas, the human GI-
tract makes up the digestive system (Fig. 2).  
          
Figure 2. Schematic representation of different regions of GI-tract. 
 
This system is responsible for breaking down food and subsequently absorbing 
nutrients. The human being and his/her intestinal microbiota, i.e. the populations 
of microbes found in the gastrointestinal tract, form a so-called “superorganism“ or 
“holobiont”, in which both parts mutually strive for survival (Relman 2012). The 
mucus layer, which coats the entire GI-tract, is the main location for host-microbe 
interactions. In the small intestine, the enterocytes of the villous epithelium are the 
main interface for digestive activities. In addition, the mucus layer of the whole GI-
tract also serves as a defence barrier to protect the host from harmful antigens, 
toxins and microbes. These distinct structural, digestive and protective functions 
constitute heterogeneous microenvironments, which in turn affect the composition 
of microorganisms attached to the epithelium or those moving along with the food 
during the digestion (Table 1).  
Stomach 
Small intestine 
Large intestine 
Rectum 
Duodenum 
Jejunum 
Ileum 
?2.1.1? How the host impacts on the intestinal microbiota 
The ways that the host exerts effects on the microbiota are multiplex. Within the 
different sections of an individual’s GI-tract, the differences in pH, oxygen level and 
mucus contents, are major elements affecting bacterial density and complexity 
(Table 1). Furthermore, long-term changes in the physiology of the whole body, 
from childhood to old age, are reflected in the structure of intestinal microbiota as 
has been observed when studying differences between healthy children, adults and 
elderly subjects (Sommer and Bäckhed 2013; Odamaki et al. 2016). In addition, 
host genotypes, environment (including diets) and normal GI-tract conditions can 
all affect the composition of microbial community, which are elaborated later in this 
section. Finally, host pathology has a profound effect on the microbiota 
composition, and sometimes could even dominate all of these other factors (see 
Section 2.1.3).   
 
Table 1. Characteristics of microbiota and host environment along GI tract. The density 
of microbiota is defined as the number of bacterial cells per gram of intestinal content. The bacterial 
taxa in the table include both luminal and mucosal taxa (McGuckin et al. 2011; Lozupone et al. 2012; 
Ohland and Jobin 2015; Zoetendal et al. 2012; Bik et al. 2006; Islam et al. 2011; Wacklin et al. 2013; 
Fallingborg et al. 1989; Leser and Mølbak 2009). The mucosal microbiota will be discussed later in 
Section 2.3.3 in detail. 
 
Gastrointestinal-tract environments 
The thickness of the mucus layer varies along the gastrointestinal tract (GIT), which 
is important to ensure optimal functionality. Mucus has two layers in both stomach 
and colon to provide protection against acidic conditions and excessive microbes. In 
contrast, only a single and discontinuous mucus layer is present in small intestine 
to allow the efficient absorption of nutrients (Johansson, Larsson, and Hansson 
2011). 
Mucus contains water (~95%), immunoglobulins (IgA), growth factors, salts, lipids, 
antibacterial proteins, trefoil factors as well as released epithelial cells (McGuckin et 
al. 2011), with mucins representing the main structural components. Mucins are 
heavily glycosylated glycoproteins, which are encoded by the MUC gene family. To 
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date, 22 human mucins have been identified as either secreted or membrane-
bound. Of these, MUC2 is the main secreted mucin in the intestine, whereas MUC5 
is the main mucin encountered in the stomach (Table 1) (Johansson, Larsson, and 
Hansson 2011). The complex mucin-attached glycans do not only serve as an energy 
source to commensal bacteria, but also act as a binding site for bacterial adhesins 
(McGuckin et al. 2011). It has been demonstrated that different types and amounts 
of glycans favor different bacteria as the attachment site to the mucus. The link 
between glycosylation of the intestinal mucus layer and microbiota composition has 
been explored in both animal and human studies (Johansson et al. 2013; Sommer 
et al. 2014; Wacklin et al. 2014; Wacklin et al. 2011). 
Once ingested, bacteria enter the GI-tract where they are confronted by the 
sequential challenges of acid stress in stomach, followed by bile and pancreatic 
secretions in the small intestine. In the stomach, the pH is less than 3 in healthy 
adults due to the presence of gastric acid (Fallingborg et al. 1989), exhibiting strong 
selective pressure which usually results in a low bacterial load (101-103 cfu/g). A 
total of 128 phylotypes from 8 phyla were detected in the gastric biopsies taken 
from 23 adults (Bik et al. 2006). The dominating phylotypes belonged to 
Streptococcus and Prevotella (Bik et al. 2006). As reported in this study, the overall 
bacterial diversity is relatively low, as compared to the about thousand species 
identified in the colon (Li et al. 2014; Browne et al. 2016). The gastric transit is 
relatively fast (1h) and some ingested bacteria survive the temporary acidic stress 
and pass into the small intestine. The stringent acidic conditions no longer exist in 
the small intestine, where the pH rises significantly from 6.4 in duodenum to 7.3 in 
ileum (Fallingborg et al. 1989). However, intestinal peristalsis and the intermediate 
transit time (8h) as compared to stomach and colon (17.5h) still prevents 
accumulation of microbiota in the small intestine, where 104-107 bacteria per gram 
of lumen content are found (Leser and Mølbak 2009). Due to the discontinuous 
single mucus layer, both luminal and mucosal microbiota can interact extensively 
with the epithelial cells. In addition, small intestinal microbiota participate in the 
formation of active, secondary form of bile acids, which are important for host’s 
regulation of lipid and glucose metabolism (Floch 2005; Islam et al. 2011). Most 
dietary nutrients, i.e. proteins, carbohydrates and fats, are digested and absorbed in 
the small intestine. Poorly digested non-starch polysaccharides make up the major 
component of dietary fibre that is metabolized in the large intestine (Floch 2005).  
The large intestine serves as a bioreactor for the fermentation of both diet- and 
host-derived glycans. The pH is 5.7 in caecum and it rises gradually from the right 
to the left colon with a final mean value of 6.6 (Fallingborg et al. 1989). There are 
two factors i.e. the more neutral pH and the availability of fermentable substrates, 
which support a dense (1010-1012 cfu/g) and more diverse microbiota (Table 1) 
(Zoetendal et al. 2012; Lozupone et al. 2012; Rajilić-Stojanović and de Vos 2014). 
To date, around one thousand gut-related bacterial species have been identified in 
the large intestine (Browne et al. 2016; Li et al. 2014; Rajilić-Stojanović and de Vos 
2014). 
Along the GI-tract from stomach to rectum, the decline in the oxygen level shifts the 
composition of microbiota gradually from facultative anaerobic to obligate 
anaerobic bacteria (Table 1).  Interestingly, oxygen forms a gradient also within the 
same anatomic location, when it diffuses across the mucosal layer to lumen and 
thereby enriches certain bacteria along this gradient (Espey 2013).  For example, 
bacteria with respiratory plasticity can tolerate low levels of oxygen for a short time 
??
and have selective growth advantage in the mucosal layer. Some strict anaerobes, 
for example, Bacteroides fragilis and Faecalibacterium prausnitzii belong to this 
group of bacteria (Khan et al. 2012; Baughn and Malamy 2004).  
Genetics 
It has been proposed that the intestinal microbiota is shaped by both genetic and 
environmental factors, such as diet (Benson et al. 2010). There are several 
observations highlighting the influence of genetic factors on the composition of the 
microbiota. For example, the microbiota is more similar among twins than between 
two unrelated individuals (Tims et al. 2013; Turnbaugh et al. 2009). However, these 
studies cannot conclude that the reason accounting for the more similar gut 
microbiota to be genotype properties without taking into account environmental 
influences.  
Although there are no conclusive genome-wide association studies (GWAS) of 
microbiota characteristics in humans, polymorphisms attributable to the presence 
of several single nucleotide polymorphisms (SNPs) have also been shown to be 
associated with the intestinal microbiota structure and composition. The 
complexity of mucus results from the highly varying extent and forms of 
glycosylation of the mucin. Genetic variation in the glycosyltransferase genes 
expressed in goblet cells explains the diverse glycosylation in different human 
populations. For instance, FUT2 is a fucosyltransferase-encoding gene, which 
determines the so-called secretor-status of the host (Wacklin et al. 2014). Secretors, 
but not non-secretors, express the ABH and Lewis histo-blood group antigens on 
mucosal surfaces, including intestinal epithelium. This secretor status has been 
claimed to explain the different structure and composition of intestinal microbiota 
in secretors, as compared to non-secretors in healthy adults (Wacklin et al. 2014). 
In general, non-secretors have been found to exhibit a lower microbial richness and 
diversity with less bifidobacteria, as compared to secretors (Wacklin et al. 2014; 
Wacklin et al. 2011). 
Host genotype also affects the specific bacterial recognition receptors. For example, 
nucleotide-oligomerization-domain-2 (NOD2) is an innate immune receptor in the 
cytoplasm of immune cells. This receptor is involved in the anti-inflammatory 
pathway in intestine. Studies on mice have revealed that NOD2 has an influence on 
specific microbiota taxa, as bifidobacteria were absent in NOD2 knock-out mice, 
displaying severe ileitis (Heimesaat et al. 2014). The risk allele for celiac disease, 
Human Leukocyte Antigen (HLA)-DQ2, was reported to determine the early 
intestinal microbiota composition in infants carrying this allele, differentiating 
them from non-carriers (Olivares et al. 2014). A lower number of Bifidobacterium 
species, and their negative correlations with several genera of Proteobacteria have 
been found to be associated with HLA-DQ2 high genetic risk allele carriers, in 
comparison to those subjects without HLA-DQ2/8 alleles (Olivares et al. 2014). 
Recently, a SNP of apolipoprotein A-V gene, which is the risk allele of metabolic 
syndrome, was found to be associated with significantly reduced abundance of 
Bifidobacterium independent of age, sex and metabolic syndrome (Lim et al. 2016). 
In view of the already established links between host genetics and microbiota 
composition, in the future, an examination of the genetic background should 
become a routine part of studies investigating host-microbiota interactions in 
different diseases. 
 
??
Diet 
Diet is considered to be a major external modulator of intestinal microbiota. All 
major dietary components, carbohydrates, proteins and fats, exert specific and 
profound effects on the composition of the intestinal microbiota (Salonen and de 
Vos 2014; Koropatkin, Cameron, and Martens 2012). In general, host-digestible 
polysaccharides break down in the small intestine to mono- and di-saccharides and 
the non-absorbed proportion of these simple carbohydrates favors the growth of 
resident Proteobacteria and Firmicutes such as Lactobacillales (Koropatkin, 
Cameron, and Martens 2012). On the other hand, host-indigestible polysaccharides, 
mainly dietary fibre, pass down into the colon, where they enrich Bacteroidetes and 
Firmicutes such as Clostridiales (Koropatkin, Cameron, and Martens 2012). 
However, the microbiota has cross-feeding networks i.e. that bacteria can use 
metabolites from other bacteria as their energy source and that break-down of 
complex substrates such as dietary fibre or mucins by specific bacteria can feed also 
other bacteria. Such cross-feeding and efficient use of available nutrients makes the 
microbial ecosystem more resilient towards dietary changes. Therefore, day-to-day 
variation may not be seen in the microbiota composition (Korpela et al. 2014; 
O’Keefe et al. 2015).  
A long-term or a habitual diet has been found to result in a more consistent and 
profound effect on the microbiota structure, as reviewed in Salonen and de Vos 
(2014). As shown in several observational studies, even with a consideration of the 
confounding effect from different ethnicities, the microbiota of inhabitants of 
western societies can still be significantly different from that of non-western 
populations (Schnorr et al. 2014; Ou et al. 2013). In general, higher microbial 
diversity and a reduced abundance ratio of Bacteroides/Prevotella are observed in 
people living in close contact with nature and consuming a fibre-based diet, such as 
the Hadza hunter-gatherers (Schnorr et al. 2014) and native Africans (Ou et al. 
2013), as compared to Western populations. These observations indicate that 
environmental factors, such as habitual diet or some kind of drastic changes of diet, 
at least to some degree, have greater effect than the host genotype in shaping the 
microbiota structure. This effect has been also detected in both human and animal 
intervention studies (O’Keefe et al. 2015; Carmody et al. 2015). For example, the 
changes of microbiota structure and composition of inbred, transgenic and outbred 
mice change rapidly and reversibly in response to the fat and sugar levels in the diet 
(Carmody et al. 2015). Switching from a habitual diet with a high fibre and low fat 
to high fat and low fibre diet in rural Africans leads to reduced co-occurrence of 
potential butyrate producers and bacterial taxa utilizing complex carbohydrates 
(O’Keefe et al. 2015).  
 
2.1.2? The effects of microbiota on host 
The intestinal microbiota participates in various digestive processes including 
salvage of energy to support host growth. Approximately 5% of the daily caloric 
requirement is estimated to be provided by the fermentation of non-digestible 
dietary residues, also named dietary fibre (Frayn 2010). The fermentation of dietary 
fibre is one of the key metabolic pathways and it produces metabolites, such as 
short-chain fatty acids (SCFA), including acetate, propionate and butyrate (Frayn 
2010). In addition, the microbiota participates in synthesizing vitamins such as 
folate and biotin and affects host iron sensing (Floch 2005; Deschemin et al. 2016). 
??
Furthermore, the microbiota and its products affect both physical and 
immunological barriers which protect the host against endogenous or exogenous 
threats (Bischoff et al. 2014).  
The role of microbiota in physical barrier of the host 
In the intestinal tract, microbiota, gastric juice, pancreatic enzymes, mucus and an 
epithelium monolayer constitute a physical barrier against pathogens (Viggiano et 
al. 2015)(Fig. 3A). The epithelial cell monolayer consists of different types of 
intestinal epithelial cells (IECs) and intercellular junctions, such as tight junctions 
(TJ). IECs, originating from stem cells present in the crypt, give rise to four main 
cells types: enterocytes, goblet cells, enteroendocrine cells and Paneth cells (Turner 
2009; Umar 2010). Enterocytes are the predominant cell type, making up >80% of 
all small intestinal epithelial cells (Umar 2010). Goblet cells produce a variety of 
mucins and trefoil peptides needed for mucus renewal and epithelial growth and 
repair (Umar 2010) (Fig. 3A). Enteroendocrine cells secrete hormones, which 
regulate food intake, intestinal transit, release of digestive enzymes, barrier 
function and immune responses (Furness et al. 2013). Paneth cells secrete 
defensins, regenerating islet-derived protein 3 (RegIII) and antimicrobial peptides 
(AMPs) in the villous crypt (Bischoff et al. 2014). All these anti-microbial products 
and secretory IgA (sIgA) are important in restricting bacterial colonization in crypts 
to maintain the normal gut epithelium homeostasis (Bischoff et al. 2014). 
TJs are considered as an essential structure for controlling intestinal permeability 
and enterocyte polarity (Turner 2009; Bischoff et al. 2014). They are formed by 
multiple proteins including occludins and members of the claudin family as the 
major sealing proteins (Turner 2009; Bischoff et al. 2014)(Fig. 3B). The sealing 
proteins interact with cytoplasmic proteins, such as zonula-occludens proteins 
(ZO), functioning as adaptors between the TJ proteins and other proteins such as F-
actin within the cells (Turner 2009; Viggiano et al. 2015). Breakdown of this barrier 
potentially leads to the translocation of luminal antigens, microbiota and their toxic 
products into the lymphocytic and blood streams (Turner 2009).  
Intestinal microbiota itself forms a natural defence barrier by competing with 
pathogens for ecological niches and nutrients (O’Hara and Shanahan 2006). 
Furthermore, it processes the molecules necessary for the optimal functioning of 
the mucosa and strengthens intestinal barrier function. For example, SCFAs, 
particularly butyrate in the colon, provide an energy source for enterocytes and 
control the differentiation and proliferation of IECs in healthy or colonic cancer 
cellular phenotypes (Comalada et al. 2006; Ulluwishewa et al. 2011; Leonel and 
Alvarez-Leite 2012). Moreover, SCFA can promote the production of mucins and 
up-regulate the expression of TJ proteins (Peng et al. 2009; Plöger et al. 2012).  
The role of microbiota in the immunological barrier of the host 
The intestinal epithelium is not only a physical barrier. Its secreted products 
constitute also an immunological barrier with specialized protective adaptations. 
Furthermore, in lamina propria (LP), immune cells combat invading microbes and 
act to eliminate them (Peterson and Artis 2014). Intestinal microbiota, especially 
commensals, participate in educating the immune system and maintaining the gut 
homeostasis in the intestine, including both innate and adaptive immunological 
activities. For example, germ-free animals do not develop normal immune system, 
as reviewed in Round et al. (2009).  
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Figure 3. Simple diagram of human small intestinal barrier in healthy individuals.  A) 
Schematic diagram of intestinal barrier. Due to the high ratio of Peyer’s patches (not depicted in the 
figure) in the mucosa, ileum is considered as the main immune sampling site (Bischoff et al. 2014; 
Kaukinen 2013). B) Tight junctions between intestinal epithelial cells (Turner 2009).  
In the lamina propria of small intestine, Peyer’s patches (PP) are a specialized gut-
associated lymphoid tissue (GALT), where antigen sampling from the gut lumen 
and the introduction and regulation of immune responses take place. In the small 
intestine, the sampling of luminal antigens is initiated by specialized epithelium 
cells, microfold cells (M cells) or dendritic cells (DCs), which can penetrate through 
the epithelium to sample luminal contents (Fig. 3). An antigen that is presented by 
M cells can be further passed on to professional antigen presenting cells (APC), 
including macrophages, B cells and DCs (Furness et al. 2013).  
Specialized recognitions between host and microbes are critical initial steps for 
their interactions. Host recognition of microbe-associated molecular patterns 
(MAMPs, microbial ligands) is mediated by pattern recognition receptors (PRRs), 
such as the Toll-like (TLRs) and NOD-like (NLRs) receptors (Table 2, Fig. 3) 
(Perez-Lopez et al. 2016; Peterson and Artis 2014). These PRRs are expressed in 
host IECs or immune cells, either on the cell surface or in the cytoplasm (Peterson 
and Artis 2014; Furness et al. 2013). The expression of PRRs is different in IECs 
from that in immune cells, and it also differs between the apical and basolateral 
sides of the IECs (Peterson and Artis 2014; Daig et al. 2000). For example, TLR9 is 
located on the IECs surface, but resides in the endosomes in immune cells 
(Peterson and Artis 2014). Moreover, the stimulation of PRRs at only the 
basolateral side of IECs contributes to the pathogenic activation, while the 
stimulation at apical sides of IECs is predominantly associated with commensal 
signaling (Kant et al. 2014; Peterson and Artis 2014). The recognition of MAMPs by 
TLRs leads a cascade of signalling, which is mediated through multiple adaptor 
molecules, such as myeloid differentiation primary response gene 88 (MyD88), 
which in turn activate key regulatory pathways, such as nuclear factor-kB (NF- kB) 
(Perez-Lopez et al. 2016). 
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Among all APCs, DCs are the most efficient and they possess enhanced ability to 
stimulate näive T cells (both CD4+ and CD8+) and subsequently induce the 
differentiation of antigen-specific T cell subsets, playing an important role in 
adaptive immunity (Jenkins et al. 2001; Perez-Lopez et al. 2016).  
Table 2. Important pattern recognition receptors (PRRs), their recognized 
microorganisms and localization in human immune cells.   
PRR Recognized microbial 
structures/molecules 
Recognized 
microorganisms 
PRRs in the host immune 
cell 
TLR1 Triacyl lipoproteins G- bacteria Cell surface 
TLR2 Lipoteichoic acid 
Lipoproteins 
Peptidoglycan 
Lipomannan 
Zymosan 
Bacteria 
 
 
Mycobacteria 
Yeast 
Cell surface 
TLR3 Double-stranded RNA Viruses Endolysosomal membrane 
TLR4 Lipopolysaccharide G- bacteria Cell surface 
Endolysosomal membrane 
TLR5 Flagellin Bacteria Cell surface 
TLR6 Diacyl lipoproteins 
Lipoteichoic acid 
Zymosan 
G+ bacteria 
Mycoplasma 
Yeast 
Cell surface 
TLR7 sRNA RNA virus 
Bacteria 
Endolysosomal membrane 
TLR8 sRNA Virus 
Bacteria 
Endolysosomal membrane 
TLR9 Unmethylated CpG DNA 
RNA::DNA 
Bacteria 
Virus 
Endolysosomal membrane 
TLR10 Unknown Listeria 
Influenza A 
Cell surface 
NOD1 Meso-diaminopimelic 
acid 
Bacteria Cell cytoplasm 
NOD2 Muramyl dipeptide Bacteria Cell cytoplasm 
G-, Gram-negative bacteria; G+, Gram-positive bacteria; sRNA: single-stranded RNA; RNA::DNA: 
RNA and DNA hybrids 
Microorganisms, especially commensal bacteria, are crucial in the induction of 
naïve CD4+ T cell differentiation to defence- or tolerance-directed T cell populations 
(Campbell 2014). T helper 1 (Th1), Th2 and Th17 are defence-directed T cell types, 
which promote cell mediated immunity, humoral immunity and the recruitment of 
phagocytic granulocytes, while regulatory T cells (Treg) regulate the balance 
between these three immune response patterns  (Fig. 3) (Campbell 2014; Ohland 
and Jobin 2015). The differentiated T cell populations together with their secreted 
cytokines can form pro-inflammatory dominating or anti-inflammatory dominating 
immune profiles, where a balance in their ratio is believed to initiate tolerance to 
??
normal gut microbiota in early life as a way of maintaining intestinal immune 
homeostasis (Fig. 3) (Di Mauro et al. 2013). 
SCFAs, including acetate, propionate and butyrate, exert extensive effects on the 
immune system, as reviewed in Vinolo et al. (2011a) and Papato et al. (2014). 
Importantly, SCFA, particularly butyrate can stimulate the production of IgA (Kim 
et al. 2016), promote the differentiation and proliferation of regulatory T cells 
(Smith et al. 2013), and inhibit nuclear factor-kB activation (Vinolo et al. 2011b) 
and thus act as anti-inflammatory agents. In summary, there is a complex 
relationship between microbiota, IECs and the immune system and their 
interactions need to be balanced in order to provide an adequate level of defence 
while avoiding exaggerated reaction towards commensals to maintain intestinal 
health. 
 
2.1.3? Intestinal homeostasis in autoimmune diseases  
In the past decade, there has been considerable interest about the role of intestinal 
microbiota in health and disease, since it has been hypothesized that the protective 
intestinal barrier could be fortified by direct contact with commensal bacteria and 
their metabolites. Furthermore, intestinal microbiota may provide functional and 
diagnostic biomarkers that are potentially novel avenues for interventions (Table 
3).  Common approaches usually rely on high-throughput and other molecular 
techniques to determine compositional and functional microbial signatures in the 
comparison of intestinal samples between healthy and compromised subjects 
(Zoetendal, Rajilic-Stojanovic, and de Vos 2008). In these comparisons, the concept 
of microbial dysbiosis or imbalance is often utilized (Cheng et al. 2013).  This 
relates to the absence of resilience in the microbial ecosystem resulting in 
permanent disturbances in the microbiota, in contrast to the stability observed in 
healthy subjects (Zoetendal, Rajilic-Stojanovic, and de Vos 2008; Jalanka-Tuovinen 
et al. 2011). On the other hand, microbial dysbiosis has also been linked to an 
altered composition of the microbiota in comparison to healthy subjects (Round 
and Mazmanian 2009). 
 
Table 3 Potential biomarkers of GI microbiota in autoimmune disease. Adapted from 
(Cheng et al. 2013)   
Disease Association with disease Association with health 
CeD R.torque like species Bifidobacteria 
IBD R.gnavus, R.torque F.prausnitzii, A.muciniphila 
T1D - Bifidobacteria 
R= Ruminococcus; F= Faecelibacterium; A= Akkermansia; -indicates that no clear association has 
been reported. 
 
In general, the intestinal microbiota of subjects with autoimmune diseases has been 
found to harbour increased numbers of bacteria that are believed to induce 
inflammation. Figure 4A depicts a general model for the relationship between 
microbial dysbiosis, compromised barrier function and intestinal inflammation 
(Cheng et al. 2013). The microbial dysbiosis is manifested as a reduction in the 
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abundances of protective bacteria, also called symbionts, resulting in a 
compromised mucosal barrier (Fig. 4B) (Round and Mazmanian 2009). The role of 
microbial dysbiosis in the pathology of inflammation is not well characterized. It 
has been proposed that dysbiotic microbiota with increased proportions of pro-
inflammatory bacteria or pathobionts can induce non-specific inflammation which 
may impair the epithelial integrity and promote further inflammation (Fig. 4B) 
(Kirjavainen et al. 1999; Round and Mazmanian 2009; Pastorelli et al. 2013). 
Alternatively, as discussed before, different types of microbes can induce the 
differentiation of different T cell populations, such as Th1, Th2, Th17 and Treg, 
which are associated with either pro- or anti- inflammatory properties (Fig. 4B). 
The ratio of Th1/Th2 cell populations is important in the pathogenesis of 
autoimmune diseases (Th1-polarization) and allergies (Th2-polarization) (Campbell 
2014; Rivas et al. 2015). Therefore, microbial dysbiosis may also contribute, 
together with impaired barrier function, dys-regulated immunity and subsequently 
to the appearance of mucosal inflammation (Cheng et al. 2013; Ohland and Jobin 
2015; Round and Mazmanian 2009). Regardless of the triggering factors, intestinal 
inflammation may elicit a vicious circle with a progressive disruption of intestinal 
homeostasis (Fig. 4A) (Cheng et al. 2013; Kirjavainen et al. 1999; Ohland and 
Jobin, 2015). The actual order of the events may vary and, at present, we lack 
convincing evidence from longitudinal studies, i.e. disease progression being 
monitored from a healthy status to the disease diagnosis in the same individuals.                   
 
Figure 4. Involvement of microbiota in the regulation of immune homeostasis in 
autoimmune diseases. A) Model for the relationship between microbial dysbiosis, mucosal 
barrier function and inflammation, modified from (Cheng et al. 2013). B) Microbiota direct the 
differentiation of both pro- and anti-inflammatory T cell populations, modified from (Round and 
Mazmanian 2009).  
The studies conducted so far have generated some considerable insights into the 
role of the intestinal microbiota in major autoimmune diseases such as CeD, IBD 
and T1D (Table 3).  
 
2.2?The development of a healthy microbiota 
The structure and composition of the human intestinal microbiota results from the 
co-evolution between host and their microbes. Up until now, the majority of studies 
on intestinal microbiota in health and diseases have focused on fecal microbiota, 
since feces are accessible in a non-invasive manner and it is easy to obtain. 
Therefore, this literature review is mostly based on studies utilizing feces as the 
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study material and thus intestinal microbiota refers to fecal microbiota, unless 
specified otherwise.  
So far, the compositional and functional development of intestinal microbiota in 
childhood has not been well characterized compared to young infants and adults. 
Some observational studies suggest that the composition of the microbiota 
community is fully developed already at 2-3 years of age, although the community 
structure and diversity in toddlers still differs from that of adults (Bergström et al. 
2014; Koenig et al. 2011; Yatsunenko et al. 2012). Furthermore, the development of 
mucosa-associated microbiota, which is considered to be of crucial importance in 
determining host-microbiota interactions, is still poorly understood. 
 
2.2.1? Characteristics of healthy intestinal microbiota in adulthood  
Taxonomic diversity 
The GI-tract, particularly the colon, has the highest density and greatest variety of 
bacteria in the human body, up to 1012 bacterial cells per gram of feces (Sommer 
and Bäckhed 2013). Bacteria are the most predominant microorganisms living in 
the gut, representing ~93% of all microorganisms, although a small amount of 
Euryarchaeota (0.9%, Archaea phylum), fungi (0.1%) and other eukaryotic 
microorganisms (0.4%) inhabit the human GI-tract (Arumugam et al. 2011). 
Furthermore, approximately 108 virus particles per gram of wet weight have been 
found in human feces, most of which are phages (Breitbart et al. 2008).  
A healthy gut microbiota is dominated by anaerobic bacteria, which outnumber 
aerobic and facultative anaerobic bacteria by 100- to 1,000-fold (Sommer and 
Bäckhed 2013). At present, around 1000 species have been identified from the 
human intestine (Rajilić-Stojanović and de Vos 2014; Li et al. 2014). The latest 
update was provided by Browne et al., who detected 137 novel culturable bacterial 
species in healthy fecal samples (Browne et al. 2016). The five most dominant 
bacterial phyla within the human GI-tract are Firmicutes (19.8-65.6 % of the total 
microbiota), Bacteroidetes (0.1-64.9%), Actinobacteria (1.1-32.5%), Proteobacteria 
(0.1-21.2%), and Verrumicrobia (0-8.8%) (Fig.2) (Arumugam et al. 2011). 
Bacteroidetes and Firmicutes are consistently characterized as the most 
predominant phyla and they can be detected in virtually all adults, although their 
relative proportions may vary considerably (Eckburg et al. 2005; Qin et al. 2010; 
Arumugam et al. 2011). However, at the bacterial species level, there is extensive 
inter-individual variation in the microbial communities, considerably greater than 
that observed at the phylum level (Jalanka-Tuovinen et al. 2011; Qin et al. 2010; 
Rajilić-Stojanović et al. 2012).  
In each individual, several hundred species of intestinal bacteria form a resilient 
ecosystem, characterized by a high level of diversity but temporal stability (Rajilić-
Stojanović et al. 2009; Bäckhed et al. 2012; Human Microbiome Project 
Consortium 2012; Qin et al. 2010). According to a cross-continent cohort study of 
39 individuals, the major genera in the gut are Faecalibacterium (5.1%), 
Bacteroides (13.9%), Prevotella (4.4%), Bifidobacterium (4.5%), Roseburia (2.6%) 
and Collinsella (1.8%) (Fig.2) (Arumugam et al. 2011). In general, Bacteroides is the 
most abundant genus, but there is very large inter-individual variation (Fig. 5).  
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Characteristics of this complex ecosystem 
In addition to the high diversity, the hallmarks of a normal intestinal microbiota are 
individual specificity, temporal stability, and conserved key functions (Faith et al. 
2013; Muegge et al. 2011; Rajilić-Stojanović et al. 2012; Bashan et al. 2016). The 
microbiota profiles from the same individual sampled a few days, months or even 
years apart are more similar to each other than to microbiota profiled at the same 
time from another individual (Faith et al. 2013; Rajilić-Stojanović et al. 2012; 
Jalanka-Tuovinen et al. 2011). For example, Faith et al. followed 37 healthy adults 
and reported that after five years, 60% of the original strains were still present 
(Faith et al. 2013). Furthermore, Rajilić-Stojanović et al. followed five healthy 
individuals for up to 12 years, and observed that the overall microbiota profiles 
were very stable during that time, although there were some variations in the 
stability of different phyla (Rajilić-Stojanović et al. 2012). The intestinal microbial 
ecosystem can be influenced by many factors such as genetics and diet. 
Interestingly, the microbial taxonomic composition generated by 16S rRNA 
sequencing correlates individually with its functional measurements of microbiota 
by a metagenomic approach, where 33 mammalian species were compared at one 
time point, suggesting that it is possible to predict microbial activity from 
microbiota composition (Muegge et al. 2011). This hypothesis has been confirmed 
at protein level by metaproteomic analyses of long-term human fecal samples 
(Kolmeder et al. 2012). Based on this hypothesis, an algorithm named PICRUSt was 
developed and benchmarked for predicting bacterial functional contents from their 
taxonomic composition (Langille et al. 2013). 
 
Figure 5. Human intestinal microbiota composition (updated from Cheng et al 2013) 
 
Despite the individual-specific composition, the gut microbiota has extensive 
functional redundancy, such that the presence of major metabolic pathways was 
found to be rather similar between individuals (Muegge et al. 2011; Human 
Microbiome Project Consortium 2012; Turnbaugh and Gordon 2009). These 
conserved key metabolic pathways are essential for all bacteria, for example 
ribosome and translational machinery, nucleotide metabolism, ATP synthesis and 
carbohydrate metabolism (Human Microbiome Project Consortium 2012; Muegge 
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et al. 2011; Qin et al. 2010; Turnbaugh and Gordon 2009). In addition to the 
evidence emerging from metagenomics studies, the conserved “core” pathways were 
also observed at the protein level (Kolmeder et al. 2012). Furthermore, the 
functionality of microbiota seems to be relatively stable, as indicated by 
metaproteome profiles of fecal samples from the same individuals taken at different 
times of one year (Kolmeder et al. 2012). In addition to the functional redundancy 
in colonic microbiota, some degree of functional redundancy would be expected 
also in the microbiota found in different parts of the intestinal tract. For example, 
two mucosa-associated Firmicutes, Lactobacillales and Clostridiales, carry out 
digestive functions of harvesting energy from carbohydrates, but perform these 
tasks in different parts of the intestinal tract, i.e., small and large intestine, 
respectively (Ohland and Jobin 2015).    
Microbiota stratification 
The microbial features that are associated with diseases can be characterized by 
comparing the microbial compositions between normal and disease states. 
However, the complexity of intestinal microbial ecosystem often leads to a high 
level of between and within-individual variations, resulting in limited consensus on 
what should represent a normal or healthy microbiota that can be generalized in all 
populations (Lozupone et al. 2012). In order to stratify microbiota at the population 
level, two concepts have been introduced: core microbiota and enterotype 
(Arumugam et al. 2011; Turnbaugh and Gordon 2009; Sekelja et al. 2011; Wu et al. 
2011).  
The core microbiota is defined as a set of abundant microbes shared by all or at 
least most subjects (Turnbaugh and Gordon 2009). The thresholds for the 
abundance and prevalence of bacteria to be included in the core still vary between 
the studies. For example, in some individuals, common commensals such as 
Faecalibacterium prausnitzii and Roseburia intestinalis may have low abundance 
and have been excluded from the core in one report (Turnbaugh and Gordon 2009), 
but included in another study (Jalanka-Tuovinen et al 2011). The healthy core in a 
Finnish study which examined nine subjects contained around 280 phylotypes 
belonging mainly to two groups of Firmicutes: Clostridium clusters IV and XIVa 
(Jalanka-Tuovinen et al. 2011). Phylotypes assigned to these two Firmicutes have 
also been observed as core members by other investigators (Qin et al. 2010; Sekelja 
et al. 2011). Therefore, the core microbiota approach is clearly dependent on the 
study designs. If one wishes to include different study populations with varying ages 
and nationalities, then defining what represents the core microbiota will become 
even more challenging. The taxonomic core microbiota determined in U.S. children 
will be discussed in Section 2.2.2 and in publication III of this thesis. 
Unlike the core microbiota approach, which includes microbes according to their 
abundance and prevalence, an enterotype analysis focuses on the functional 
interactions between microbes such that an enterotype refers to the co-existence of 
certain microbes which might contribute to the same function at a population level 
(Arumugam et al. 2011). In the EU MetaHIT consortium project, Arumugam et al. 
found three enterotypes including Bacteroides, Prevotella and Ruminococcus as 
the main driving genera in the bacterial communities, while the US Human 
Microbiome Project (HMP) confirmed only two of them (Bacteroides and 
Prevotella) (Arumugam et al. 2011; Wu et al. 2011). Interestingly, these two 
enterotypes were found to correlate with habitual diets (Wu et al. 2011). The 
difference in the number of enterotypes revealed by these two studies may be 
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attributed to the geographic variation between EU and US or differences in the 
microbiota assessment platforms. Furthermore, additional enterotypes might 
become evident when children and other populations are included in the analyses. 
For example, the clear differences in microbiota composition between infants and 
adults may indicate the presence of age-related novel enterotypes, while the clear 
difference between adults from Malawi or Venezuela and US (Yatsunenko et al. 
2012) may indicate the presence of novel geography-enterotypes in addition to 
those already described. However, the concept of “enterotype” was challenged by 
Knights et al. (2014), where the majority of the analysed data in the microbiome 
studies demonstrated a continuous gradient of dominant taxa rather than discrete 
enterotypes.  
 
2.2.2?Compositional changes of microbiota in childhood and 
influencing factors  
The colonization, diversification and establishment of human intestinal microbiota 
has been considered as a step-wise process, which is influenced by a number of 
factors (Rautava, Luoto, et al. 2012; Nylund et al. 2014). The major introduction of 
both microbial and dietary antigens happens during infancy (0-3y) and it is 
influenced by many perinatal events and early life nutritional changes, resulting in 
major colonization and diversification of intestinal microbiota. This is reflected in 
the rapid increase in the diversity and stability of the microbiota that occurs during 
the first year of life (Fig. 6) (Rautava, Luoto, et al. 2012; Nylund et al. 2014). In 
general, the intestinal microbiota is less stable in early life than in adulthood (Fig. 
6) (Yatsunenko et al. 2012). Therefore, early life is considered to be a critical period 
for developing tolerance towards commensals and maturating immune system (Di 
Mauro et al. 2013; Isolauri 2012; Rautava, Luoto, et al. 2012) (Fig. 6). 
 
Figure 6. Development of tolerance towards commensal bacteria. Intestinal microbiota 
diversity reflects both how many microbes are present (richness) and their distribution pattern 
(evenness) in the ecosystem, while stability reflects the structural configuration of the ecosystem 
over time. Both diversity and stability may be reflected in the host-microbe and environment-
microbe interactions. As discussed in Section 2.2.1, both diversity and stability reach their highest 
levels in adulthood, indicating that by that time, the host-microbe-environment cross-talk may also 
be established.  
Prenatal period and mode of delivery  
Traditionally, the human fetus is considered to be free from microbes and bacterial 
colonization is known to start during or soon after the birth of the newborn. In the 
past decades, this consensus has been challenged by the detection of bacterial DNA 
signatures in placenta and amniotic fluid in healthy individuals (Keski-Nisula et al. 
1997; Satokari et al. 2009; Aagaard et al. 2014). Moreover, in healthy neonates born 
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by Cesarean section, live bacteria have been found in the umbilical cord blood and 
meconium (Jiménez et al. 2005; Jiménez et al. 2008).  It may be speculated that 
the presence of microbes in utero is not necessarily linked to any pathological 
consequences, but rather to the education of the fetal’s immune system. The genera 
that have been detected in meconium using culture analysis are Enterococcus and 
Staphylococcus (Jiménez et al. 2005; Moles et al. 2013). Furthermore, the mother-
to-child microbial transmission has been confirmed by detecting Bifidobacterium 
lactis alone or mixed with Lactobacillus rhamnosus GG in placenta, after oral 
consumption of these two bacteria by their mothers in a double blinded randomized 
trial (Rautava, Collado, et al. 2012). Therefore, it has been claimed that the first 
inoculum is inherited from the mother (Jiménez et al. 2005; Satokari et al. 2009). 
However, the knowledge of maternal symbiont transmission is limited, due to the 
sterile womb paradigm, which poses ethical limitations in addition to technical 
difficulties such that it is difficult to collect samples from healthy pregnant women 
before delivery. 
Although the initial exposure to microbes could be in utero, the main microbial 
colonization is known to begin during birth, when the infant becomes exposed to 
the extra-uterine environment (Rautava, Luoto, et al. 2012). During the subsequent 
colonization process, new microbes are introduced through a variety of 
environmental contacts. Facultative anaerobic bacteria e.g. Enterobacteria, are 
replaced gradually by strict anaerobic bacteria, such as Bifidobacterium, 
Clostridium, and Bacteroides (Arrieta et al. 2014; Matamoros et al. 2013; Weber 
and Polanco 2012). The favourable microbiota seems to result from the beneficial 
co-evolutionary relationship with the infants born vaginally in full term, who 
exclusively drink breast milk during the first few months (Collado et al. 2012; 
Cheng et al. 2013). In contrast, the microbiota in Cesarean-delivered infants have 
low levels of Bacteroides and bifidobacteria and high level of Clostridium spp. 
(Grönlund et al. 1999; Adlerberth et al. 2007; Palmer et al. 2007; Kuitunen et al. 
2009). Such differences in microbial composition can even be detected in the 
infants of one year old (Grönlund et al. 1999; Adlerberth et al. 2006; Penders et al. 
2006).   
Early-life Nutrition  
Maternal nutrition plays important role in fetal development, which subsequently 
affects the fetal intestinal microbiota. After birth, breast milk is the major or even 
exclusive food for infants, containing numerous bioactive compounds, which also 
act as modulators for the infant intestinal microbiota development, as reviewed in 
Rautava (2016). 
Human milk oligosaccharides (HMO) are important modulating components for 
the infant microbiota. The number of HMOs in human breast milk is much higher 
than that in cow milk, as reviewed in Nylund et al. (2014). These oligosaccharides 
can boost the growth of bifidobacteria including some Bifidobacterium longum 
strains, and a higher level of these bacteria is thought to represent a specific 
microbial signature of the infant gut (Schell et al. 2002; Sela et al. 2008; Zivkovic et 
al. 2011; Satokari et al. 2002). In 1905, Tissier (1905) described the distinctive 
microbiota of breast-fed (BF) infants, dominated by Bifidobacterium bifidum. The 
dominant role of bifidobacteria in BF infants still seems valid today. Instead, 
formula-fed (FF) infants seem to harbor more mixed-type microbiota and harbor 
e.g. high numbers of Bacteroides in addition to bifidobacteria (Harmsen et al. 
2000), although the levels of bifidobacteria do not differ significantly between BF 
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and FF infants, summarized in Adlerberth and Wold (2009). Interestingly, 
supplement with prebiotics in formula-feeding leads to the enrichment of 
bifidobacteria and lactobacilli, which exert proctective effects to the infant, as 
reviewed in Bertelsen, Jensen, and Ringel-Kulka (2016). For example, 
Bifidobacterium longum and Lactobacillus rhamnosus GG have been reported to 
alleviate the symptoms during GI-tract infections (Guarino et al. 2014).  
Breast milk microbiota has been recently characterized as an individual-specific 
microbial ecosystem, distincting to that of the other human body compartments 
(Hunt et al. 2011; Cabrera-Rubio et al. 2012). Staphylococcus, Streptococcus, 
Lactobacillus and Bifidobacterium spp. have been detected in breast-milk by both 
cultural dependent and independent approaches, as reviewed in Gomez-Gallego et 
al. (2016). Furthermore, common core microbiota comprising seven genera has 
been proposed by Hunt et al. (2011) and Jiménez et al. (2015). Among these seven 
core genera, Staphylococcus and Streptococcus were revealed in both studies (Hunt 
et al. 2011; Jiménez et al. 2015). Breast milk microbiota may affect the infant 
intestinal microbiota development, since the same groups of bacteria, including 
Bifidobacterium spp. have been consistently detected in maternal feces, breast milk 
and the infant gut, as reviewed by both Gomez-Gallego et al. (2016) and Rautava S 
(2016).  However, the routes of transmission between mother and child are still not 
fully understood and currently under intensive investigation. 
The main diversification of the infantile microbial population starts after weaning 
from breast milk. Bifidobacteria predominate during the first few months, 
especially in BF infants (Roger and McCartney 2010). The expansion of the phyla 
Bacteroidetes and Firmicutes (including the genera Lachnospira, Clostridium and 
Ruminococcus) is associated with weaning and the introduction of solid foods at 
about 4-6 months (Fallani et al. 2011; Koenig et al. 2011). In contrast, 
Bifidobacterium spp. and Enterobacteria species abundance starts to decrease 
(Fallani et al. 2011). The conversion to an adult-type microbiota has been gradually 
achieved by 1-2 years of age (Palmer et al. 2007; Mackie, Sghir, and Gaskins 1999).  
However, the actual age of the maturation and stabilization of the intestinal 
microbiota has not been investigated sufficiently in long-term studies. For example, 
the turning point for Bifidobacterium spp. from infantile to adult-type profile has 
not been specified (Shkoporov et al. 2008). In general, the post-weaning 
diversification of intestinal microbiota could be rapidly shifted by a fibre-rich diet, 
resulting in region-specific microbial signatures in rural African children compared 
to their European counterparts (Filippo et al. 2010). More specifically, rural African 
children had a significantly higher level of SCFAs in feces, enriched Bacteroidetes 
with abundant Prevotella and Xylanibacter, and on the other hand the depletion of 
Firmicutes and lower level of Enterobacteriaceae (Shigella and Escherichia). These 
findings support the co-evolved relationship between a fibre-rich diet and specific 
intestinal microbial signatures.  
Antibiotics 
Infants, toddlers and young children are at a high risk of suffering infections. In 
Finland, high morbidity is observed within the first year of age, with an average of 4 
to 7 ear or respiratory tract infections, often accompanied by a couple of enteric 
infections (Peltola 2012). Antibiotics are among the most commonly prescribed 
drugs for young children.  
??
In general, antibiotic treatments are considered as a major perturbation of 
intestinal microbiota, resulting in reduced bacterial diversity, altered microbial 
community structure and composition (Korpela et al. 2016; Rehman et al. 2012; 
Dethlefsen and Relman 2011). These effects may be transient or persistent, 
depending on both the type and duration of antibiotic therapy. Korpela et al. 
reported that one course of macrolide therapy exerted a much stronger effect than 
penicillin on both overall microbial richness and specific microbiota abundance 
(Korpela et al. 2016). After macrolide administration, microbial richness did not 
recover to the control level even after two years, whereas no significant reduction in 
richness was found in children with penicillin treatment at six months’ post-
treatment (Korpela et al. 2016). The depletion of Actinobacteria as well as increased 
abundance of Baceroidetes and Proteobacteria due to macrolides effects persist for 
six months, while penicillin did not show similar results (Korpela et al. 2016). Oral 
administration of vancomycin achieved similar results with macrolide treatment in 
adults, such as reduced diversity and increased abundance of Proteobacteria, while 
no significantly reduced diversity was observed in adults treated with amoxicillin 
(Vrieze et al. 2014). Moreover, repeated treatments with ciprofloxacin has been 
reported to lead to incomplete recovery of microbiota to baseline, with an altered 
overall composition representing a new ecologically stable state (Dethlefsen and 
Relman 2011). 
Environmental biodiversity  
Biodiversity is the measurement of variety of all living organisms in the 
environment, including plants, animals and microorganisms. A comparison of the 
biodiversity can be conducted within species, between species and at the level of the 
whole ecosystem. In microbial ecology, recent advances in biodiversity research 
have focused on genetic diversity of populations and species, such as the 
assessment of 16S rRNA gene sequences or whole (meta) genome based high-
throughput intestinal microbiome research (Muegge et al. 2011; Human 
Microbiome Project Consortium 2012; Korpela et al. 2016).  
Environmental biodiversity, especially environmental microbiota diversity, has 
been proposed to be the link between environmental and lifestyle changes and 
human diseases, as postulated in the so-called hygiene or biodiversity hypothesis 
(von Hertzen, Hanski, and Haahtela 2011). According to this hypothesis, the lack of 
microbial exposure to natural and agriculture environments, e.g. farm, is thought to 
lead intestinal microbiota dysbiosis and skew the immune response against 
common and innocuous environmental antigens, increasing the risk of immune-
mediated diseases which will be discussed in details in Section 2.3.3 (Mutius et al. 
2010; Haahtela et al. 2013; von Hertzen, Hanski, and Haahtela 2011). Today, 
processed food contains few microbes and the exposure to microbes via the 
consumption of fermented foods is also low in Western societies (Logan, Katzman, 
and Balanzá-Martínez 2015). Furthermore, common practices such as the use of 
household disinfectants and pre-filtering incoming air through automated 
ventilation contribute to today’s excessively hygienic life-style. 
There are a number of factors that could affect intestinal microbiota development 
from fetus to adulthood, such as birth time, family size and duration of lactation 
(Fig. 7). These have been extensively reviewed recently (Rautava, Luoto, et al. 2012; 
Putignani et al. 2014; Spor, Koren, and Ley 2011; Yatsunenko et al. 2012). 
??
 
Figure 7. Host-life events that influence intestinal microbiota development. Throughout 
the life span, different internal and external factors can accumulatively affect host health either 
directly or by affecting the microbiota. Accumulated negative effects from influencing factors can 
interfere with the balance of normal microbiota, which may gradually lead to a dysbiotic microbiota 
and increased risk of disease development.  
 
Core microbiota in childhood  
In childhood, less stable intestinal microbial ecosystem often refers to less 
resilience and more sensitivity towards both internal and external perturbations, 
such as host physiology development events, infections and medications (Fig. 6 and 
Fig. 7). The accumulation of different perturbations can result in extensive 
variations in microbiota composition within and between individuals in children as 
compare to adults (Yatsunenko et al. 2012). Therefore, it is even more challenging 
to stratify the intestinal microbiota in children than in adults, and identification of 
the core microbiota might be a good approach for characterizing the development of 
intestinal microbiota in children. There are rather few studies that have 
investigated the core microbiota in children (Table 4). 
 
2.2.3 Microbial dysbiosis in early life and associations with diseases
As depicted in Figure 7, an accumulation of different perturbations might result in 
(individual-specific) dysbiosis of microbiota. Subsequently, as discussed in Section 
2.1.3, microbial dysbiosis can lead to altered mucosal homeostasis and immune-
dysregulation, which has been observed in numerous pediatric diseases, including 
metabolic diseases, allergies, autoimmune diseases, even brain disorders (Renz, 
Brandtzaeg, and Hornef 2012; Rook, Lowry, and Raison 2015). For example, a 
microbial dysbiosis associated with Caesarean section might increase the risk of 
allergy (Guibas et al. 2013) and autoimmunity (Bonifacio et al. 2011). Antibiotics- 
related changes in intestinal microbiota can influence subsequent microbial
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colonization, leading to the loss of colonization resistance and providing 
opportunities for pathogens such as rotavirus and in rare cases even Clostridium 
difficile to cause infection (Morgun et al. 2015; Viggiano et al. 2015). Furthermore, 
antibiotic treatments, particularly their overuse, increase the prevalence of 
antibiotic-resistant bacterial strains in the community; which is now one of the 
main threats to public health (Cotter, Ross, and Hill 2013; Moore et al. 2013). In 
addition, antibiotics can induce gut alterations by directly effecting the host 
epithelium and mitochondrial functions, such as decreasing the host cell viability 
(Morgun et al. 2015; Moullan et al. 2015). The use of antibiotics has recently been 
associated with the development of CeD and excessive weight gain in children with 
microbial dysbiosis as one plausible explanation (Morgun et al. 2015; Mårild et al. 
2013; Korpela et al. 2016). Furthermore, repeated antibiotic treatments in 
childhood have been linked with an increased risk for the development of Crohn´s 
disease, but not ulcerative colitis (Virta et al. 2012). The link may indicate the role 
of either antibiotics or infections or both in the development of Crohn´s disease.  
The loss of microbial biodiversity in food together with the reduced exposure to 
environmental microbes in early life in today’s Western life-style may have 
profound effects on human life, such as delayed maturation of the immune system 
and a high risk for suffering infections (Haahtela 2014). Furthermore, the loss of 
intestinal microbial biodiversity is typical in Western population can only be 
reversed by dietary means in a single generation, but not over several generations, 
as indicated in mice (Sonnenburg et al. 2016). In addition, it has been suggested 
that 50-60% of intestinal microbial genera from healthy individuals are spore-
producing bacteria, which have a better possibility of surviving a prolonged 
exposure to some common disinfectants than non-spore forming commensals 
(Browne et al. 2016). This finding highlights the possible transmission route of 
commensals between humans and the environment. On the other hand, the 
extensive use of disinfectants in modern life confers a survival advantage on the 
spore-forming pathogens such as Clostridium difficile, which might cause severe 
infectious diseases. Emulsifiers and other detergent-like molecules are ubiquitous 
components of processed Western food and their extensive use has been considered 
one potential reason for increased incidence of chronic inflammatory diseases such 
as metabolic syndrome (Chassaing et al. 2015). A possible mechanism has been 
proposed that emulsifiers in foods could disturb the production of SCFAs and bile 
acid metabolism, leading to disrupted host-microbe interactions and low grade 
inflammation (Chassaing et al. 2015). 
 
2.3?Pediatric celiac disease and microbiota 
2.3.1? Celiac disease 
Celiac disease is a chronic immune-mediated disease characterized by small 
intestinal inflammation introduced by an intolerance to gluten or related prolamins 
(Ivarsson et al. 2013). The incidence of CeD in Western countries, such as Europe 
and USA is increasing, with an approximate frequency of 1% in the general 
population (Mustalahti et al. 2010; Fasano et al. 2003). The disease prevalence 
varies extensively within Europe, with the highest prevalence encountered in 
Finnish adults (2.4%) and the lowest in Germany (0.3%) (Mustalahti et al. 2010). 
Active CeD patients typically have mucosal injury with villous atrophy affecting 
nutrient absorption as well as lymphocyte levels in the LP (Verdu, Galipeau, and 
??
Jabri 2015). The typical symptoms of CeD are diarrhea, malabsorption or even 
malnutrition in severe cases (Green and Jabri 2006). Moreover, extra-intestinal 
symptoms including dermatitis herpetiformis may also occur. Adherence to a strict 
gluten-free diet is currently the only effective treatment for CeD (Green and Jabri 
2006).  
CeD occurs in genetically predisposed individuals of all ages with the initial 
symptoms appearing at different times in different individuals - from infancy (after 
introduction of gluten-containing food) to old age (Aronsson et al. 2015). The 
progression of the disease is known to be influenced by both genetic and 
environmental factors (Fig. 8). Association studies have revealed strong genetic 
effects. Human Leukocyte Antigen (HLA) class II molecules (HLA -DQ2 or HLA-
DQ8) are the major genetic risk factors predisposing individuals to CeD, explaining 
about 40% of the genetic variance (Trynka et al. 2011). Other 39 non-HLA loci, 
including FUT2 account for about 14% of the genetic variance (Trynka et al. 2011; 
Parmar et al. 2012). Moreover, FUT2 non-secretor status was reported to have 
increased risk of CeD (Parmar et al. 2012). However, not all genetically predisposed 
individuals will eventually develop CeD, suggesting the attribution from other 
unknown genetic factors and/or environmental factors are important in CeD 
pathogenesis (Trynka, Wijmenga, and van Heel 2010; Green and Jabri 2006; 
Olivares et al. 2014; Decker, Hornef, and Stockinger 2011; Ivarsson et al. 2013; 
Canova et al. 2014).  
 
Figure 8. Influencing factors on celiac disease onset. HLA-DQ2/DQ8, infections and gluten 
ingestion directly affect epithelium integrity and immunological regulations, which subsequently 
may predispose to Th1-type immunity and disease onset (Green and Jabri 2006). Moreover, HLA-
DQ2 (Olivares et al. 2014) and other environmental factors, such as antibiotics (Mårild et al. 2013), 
delivery mode (Decker, Hornef, and Stockinger 2011), infections (Canova et al. 2014) and breast-
feeding (Ivarsson et al. 2013), can promote the disease development via dysbiotic colonization 
process during infancy.  
 
2.3.2?Pediatric celiac disease associated microbiota 
As discussed in Section 2.1.2, the intestinal microbiota is considered to be an 
important factor contributing to the homeostasis of the gut epithelium, which may 
play an essential role in the CeD onset (Fig. 8) (Verdu, Galipeau, and Jabri 2015; 
Palma et al. 2012). Several research groups have compared the microbiota 
composition in active CeD patients, gluten-free diet treated individuals and healthy 
controls in paediatric populations by examining their biopsy samples (Table 5).  
In general, as compared to healthy controls, increased abundance and/or 
prevalence of facultative bacteria, such as Staphylococcus and Proteobacteria, 
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particularly E.coli, seem to be a common feature of duodenal mucosa-associated 
microbiota in active CeD patients (Nadal et al. 2007; Collado et al. 2009; Sánchez et 
al. 2013) and are reduced after GFD treatment (Collado et al. 2009; Sánchez et al. 
2013) (Table 5). The increased levels of facultative bacteria may be associated 
primarily with intestinal inflammation. Interestingly, a shift from predominantly 
anaerobic microbiota towards a facultative anaerobic community has been 
frequently observed in IBD subjects with active disease as well, as reviewed in 
(Mukhopadhya et al. 2012; Rigottier-Gois et al. 2013). One proposed mechanism 
behind the shift is so-called “oxygen hypothesis”, which suggests that inflammation 
increases the oxygen level in mucosa, thereby favouring facultative anaerobes 
(Mukhopadhya et al. 2012; Rigottier-Gois et al. 2013). Likewise, in CeD 
inflammation may drive microbiota dysbiosis. Furthermore, increased duodenal 
mucosal microbial diversity and total bacterial counts have been observed in active 
CeD patients as compared to healthy controls (Nadal et al. 2007; Schippa et al. 
2010).  Furthermore, microbiota similarity between individuals is higher in subjects 
with active CeD than in CeD subjects on GFD or in healthy controls (Schippa et al. 
2010). Such microbiota features may also reflect inflammation driven microbial 
dysbiosis, but it is often not possible to distinguish between the effects of mucosal 
healing and the ceasing of inflammation from those induced by changes in the diet.  
GFD is the only effective treatment for CeD. The withdrawal of gluten containing 
cereals from the diet was shown to lead to decreased consumption of dietary fibre in 
adults (De Palma et al. 2009). Several studies have reported the microbiota changes 
due to GFD treatment (Table 5). The changes in microbiota composition could be 
caused not only by the withdrawal of gluten but also by the low fibre intake. 
Comparison of CeD subjects on GFD and healthy controls has provided some 
insights into the GFD induced changes in microbiota, although the observed 
differences in microbiota may also reflect incomplete recovery of microbiota from 
severe inflammation-driven microbial dysbiosis after the implementation of GFD. 
For example, decreased total counts in mucosal bacteria, contributed mainly by 
decreased counts of Bifidobacterium and Lactobacillus, in GFD individuals as 
compared to healthy controls have been reported (Nadal et al. 2007). Di Cagno et 
al. (2011) also reported increased diversity of mucosal Eubacterial community in 
GFD treated groups than that in HC, indicating the rearrangement of the species 
within this group. Bonder et al. (2016) evaluated the effect of GFD on microbiota in 
21 healthy individuals before and after four weeks GFD. Short-term GFD diet 
implementation had only a moderate effect on the abundance of several bacterial 
taxa, such as reduced abundance of Veillonellaceae, but more profound effects on 
the microbiota activities, mainly starch degradation (Bonder et al. 2016). GFD did 
not affect gut inflammation related biomarkers such as fecal calprotectin (Bonder et 
al. 2016). The result suggested that GFD does not have a significant contribution to 
the CeD-associated microbial dysbiosis.  
Although mucosal microbiota affects the host by directly communicating with 
immune cells and IECs, luminal microbiota also can modulate host immune system 
via metabolites as well as MAMP and toxin production. Microbial dysbiosis has also 
been consistently observed in CeD-associated fecal microbiota (Table 6). In some 
studies, similar patterns of microbial dysbiosis have been observed for CeD-
associated fecal and duodenal mucosal microbiotas i.e. increase in facultative 
anaerobes and diversity (Sanz et al. 2007; Collado et al. 2009; Sánchez et al. 2012). 
Interestingly, comparing to healthy controls, significantly reduced amounts of IgA-
coated bacteria was detected in both untreated and treated
? ? ?
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CeD individuals, implying the impaired host defence and barrier function (De 
Palma et al. 2010). 
To date, no consensus on celiac disease-specific microbial signature has been 
identified due to the inconsistent findings (Table 5 & 6). This might be because of 
differences in the sample materials (fecal vs. biopsy), variation in the length of 
gluten-free diet and patients’ age, biases in the methodologies (traditional methods 
vs. high-throughput microarray/sequencing) or sample sizes. It is also not known, 
whether the observed CeD-associated microbiota changes are primary and play a 
role in the disease pathogenesis or occur as a consequence of the disease 
development. The observations that delivery by caesarean section, infantile 
infections and the use of antibiotics increase the risk of developing CeD (Decker, 
Hornef, and Stockinger 2011; Mårild et al. 2013; Plot and Amital 2009) indicate 
that microbiota could play a role in the disease onset. Interestingly, the CeD risk 
allele HLA-DQ2 was reported to determine the early intestinal microbiota 
composition and the carriers had lower number of Bifidobacterium species and 
increased levels of several genera belonging to Proteobacteria (Olivares et al. 2014). 
In order to clarify the role of microbiota in CeD onset, large cohort of subjects with 
genetic predisposition to CeD should be followed in time from unaffected health 
status to the development of disease. However, it is a great challenge to accomplish 
such studies.  
 
2.3.3?Potential roles of microbiota in CeD 
The exact mechanisms explaining how intestinal microbiota could affect the 
development or onset of CeD remain unknown. The suggested pathways involve the 
modulation of epithelial integrity and innate immunity as well as exacerbation of 
gliadin-induced immune responses (Verdu, Galipeau, and Jabri 2015). 
Gluten contains considerable amounts of proline and glutamine amino acids, which 
make it resistant to enzymatic digestion in the small intestine (Shan et al. 2002). 
These long gliadin peptides subsequentially pass through the intestinal mucosa 
where they are deaminated by tissue transglutaminase 2 (TG2) in LP, captured by 
DCs which then trigger pro-inflammatory gluten-specific CD4+ T cell responses 
(Shan et al. 2002; Green and Jabri 2006). These gluten-specific immune responses 
include the production of IFN-γ, anti-tissue TG (tTG) antibodies, anti-gliadin 
antibody and anti-endomysial antibodies (EMA) in susceptible individuals (Shan et 
al. 2002; Green and Jabri 2006). Tissue damage, such as the increased mucosal 
permeability encountered after the upregulation of zonulin or some other 
mechanisms triggered during a gastrointestinal infection, might explain why long 
gliadin peptides could pass through the mucosa to LP (Fasano et al. 2000). The role 
of intestinal microbiota in the progression, or onset of CeD, could be either positive 
or negative. Clostridium spp., Streptococcus spp. and coliforms are the 
predominant bacteria in the small intestine, and these organsims might contribute 
to rapid responses to dietary changes (Zoetendal et al. 2012). Furthermore, 
Clostridium spp., particularly members of the Clostridium cluster XIVa, not only 
can transform undigested polysaccharides into butyrate directly, but can also 
indirectly convert lactate produced by Streptococcus spp. to butyrate, which is a 
crucial metabolite promoting epithelium integrity (Zoetendal et al. 2012). In vitro, 
Bifidobacterium lactis and B. bifidum have been shown to be protective against 
gliadin-induced barrier dysfunction in epithelial cell lines (Cinova et al. 2011; 
??
Lindfors et al. 2008). In contrast, E. coli and Shigella have been demonstrated to 
increase the translocation of gliadin-peptides into LP (Cinova et al. 2011). 
Furthermore, Bacteroides fragilis and Akkermansia muciniphila have been 
reported to improve epithelial integrity (Reunanen et al. 2015). In addition, 
commensals as a whole can be considered as a physical barrier against pathogens, 
while butyrate produced by specific bacteria could strengthen the epithelium 
barrier function, as discussed already in Section 2.1.2. 
Microbiota may affect the progression of CeD via immune modulation, including 
both the innate and adaptive arms of the immune system (Green and Jabri 2006). 
The combination of both a enhanced response to bacterial ligands and microbial 
dysbiosis may lead to cytokine and chemokine profiles that are predominantly pro-
inflammatory. For example, duodenal biopsies from Finnish CeD patients were 
found to have altered duodenal expression of TLRs and their inhibitor which is 
indicative the involvement of innate immunity and bacterial ligand recognition in 
CeD (Kalliomäki et al. 2012). Furthermore, carriers of SH2B3, a risk allele for CeD, 
have enhanced activation of the NOD2 recognition pathway, which is important in 
bacterial pathogen recognition (Zhernakova et al. 2010). For exploring the exact 
roles of microbiota in the pathogenesis of CeD, microbiota with and without a 
pathobiont, E. coli, was introduced into germ-free mice with HLA-DQ8-genotype 
(Galipeau et al. 2015). The presence of E. coli exacerbated the development of 
gluten induced pathology and, if the microbiota was devastated with vancomycin 
treatment the pathology was further increased in the presence of E. coli (Galipeau 
et al. 2015). The dysbiotic microbiota containing E.coli evoked both an increased 
pro-inflammatory gliadin specific T-cell response and increased IgA anti-gliadin 
antibody production as compared to microbiota without E.coli (Galipeau et al. 
2015). Increased IL-15 levels are associated with active CeD (Jabri et al. 2000) and 
Gram-negative bacteria derived LPS may play a role in stimulating IL-15 production 
through TLR4 activation (Re et al. 2004) and thus modulating the immunological 
environment. This might suggest some involvement of LPS-carrying members of 
the gut microbiota, particularly Proteobacteria, in the IL-15 upregulation. On the 
other hand, B. fragilis might prevent and reverse the intestinal inflammation in 
CeD by enhancing Treg cells and anti-inflammatory cytokines production. 
Intrestingly, B. fragilis produces polysaccharide A (PSA), which activates TLR2 
signalling and it releases PSA-containing outer membrane vesicles to deliver 
immunoregulatory effects to the host (Shen et al. 2012).  
 
2.4?Methodology to study intestinal microbiota 
A detailed characterization of the microbial composition is the first step in the 
exploration of the role of this complex ecosystem in health and disease. To date, a 
variety of approaches have been applied. Traditional culture-based methods can 
detect those bacterial species that can be cultivated on laboratory media, but these 
kinds of bacteria constitute only 10 to 50% of the microbiota (Eckburg et al. 2005). 
Great advances have been made through the application of culture-independent 
techniques, which allow broader and less biased profiling of the microbiota 
(Zoetendal et al., 2008). The 16S rRNA gene (approximately 1500 bp, 16S rDNA) is 
the most often used phylogenetic marker (Kuczynski et al. 2012) and the culture-
independent methods are generally based on the analysis of this gene. 16S 
ribosomal RNA is a structural component of the 30S subunit of all prokaryotic 
??
ribosomes. The 16S rRNA gene contains conserved and variable regions. The 
conserved regions can be used for designing broad spectrum primers and variable 
regions are valuable for genus/family level classification (Kuczynski et al. 2012). 
The similarity of the detected 16S rRNA gene sequence to those of cultured bacteria 
or previously identified sequences represents the basis for analyzing microbiota 
composition using this approach.   Phylotype or OTU (operational taxonomic unit) 
is used to describe bacterial species detected by 16S rRNA gene sequence analysis, 
since a true identification of bacteria requires a phenotypic characterization. 16S 
rRNA gene sequences can be clustered according to their similarities, resulting in 
different corresponding taxonomic unit (OTU) levels. Cut-off values of 97-99% and 
90% similarity between 16S rDNA sequences are often referred to as phylotype or 
OTU and genus level classification, respectively (Rajilić-Stojanović et al. 2009).  
Common 16S-based techniques include fingerprinting techniques, such as 
denaturing/temperature gradient gel electrophoresis (D/TGGE) and terminal- 
restriction fragment length polymorphism (T- RFLP) for microbiota community 
profiling, and quantitative real-time PCR (qPCR) and fluorescent in situ 
hybridization (FISH) for targeted detection and quantification of specific bacterial 
taxa or species (Satokari et al. 2003). The low-resolution microbiota community 
profiling techniques, such as D/TGGE and T-RFLP have been replaced by high 
throughput (HT) approaches. On the other hand, qPCR is highly sensitive and 
requires a relatively small amount of template, and thus it has been extensively 
used for verifying the results obtained from HT microbiota analysis (Bacchetti De 
Gregoris et al. 2011).  
DNA microarrays and next generation sequencing (NGS) are commonly used HT 
methods in RNA/DNA analysis (Kuczynski et al. 2012). Human Intestinal Tract 
Chip (HITChip), a bacterial phylogenetic microarray, has been applied extensively 
in human intestinal microbiota studies investigating both healthy subjects and 
individuals affected by various diseases, such as atopy, obesity, IBS and IBD 
(Korpela et al. 2016; Jalanka et al. 2015; Nylund et al. 2013; Rajilić-Stojanović et al. 
2009). NGS techniques have been developed to allow massive parallel amplification 
of a vast number of (partial) 16S/18S rRNA genes or total community DNA from 
complex microbial ecosystems and facilitate rapid and holistic characterization. 
When the whole intestinal microbiota DNA is determined by NGS, this approach is 
termed metagenomics (or whole-genome shotgun sequencing) (Lepage et al. 2013; 
Nielsen and Ji 2015). The main difference of metagenomics from the 16S rRNA-
based approach is the detection of the whole genetic potential i.e. collective 
genomes and capacity (functions) of the sampled ecosystem instead of only its 
phylogenetic composition. Thus, metagenomics generates both phylogenetic and 
genomic information, and thus it also provides insights into the potential functions. 
Miseq and Hiseq (Illumina), Ion Torrent (Life Technologies) and Single-molecule 
real-time sequencing (SMRT, Pacific Biosciences) are currently used NGS 
platforms. The details of these platforms have been recently reviewed in (Reuter, 
Spacek, and Snyder 2015; Lepage et al. 2013; Nielsen and Ji 2015). The essential 
steps in 16S rRNA gene based microbiota analysis and specific challenges in each 
step are summarized in Table 7. Notably, as reviewed in Lozupone et al. (2013), the 
16S rRNA region, sample preparation protocol and sequencing platforms are all 
major resources for technical variation, which can affect the results obtained. 
Therefore, experimental design considerations, such as the selection of control 
populations, adequate cohort sizes and standardized protocols, including both wet- 
??
and dry lab procedures, are recommended for controlling for unwanted 
confounding effects.  
 
Table 7. Steps and challenges in 16S rRNA gene based microbiota analysis  
Step Key point Reference 
Experimental 
design 
 
 
 
 
Study population 
 
 
 Confounding effects: age and antibiotics 
usage are important confounders in microbiota 
research. For example, intestinal microbiota is 
considered to be relatively stable only after 3 
years of age. Therefore, the age between the 
compared populations should not differ too 
extensively when young children are being 
studied. Regarding the confounding effect 
from antibiotics, it might require one year or 
even longer recovery time, for gut microbiota 
to return to baseline composition, or it may 
never return. Therefore, any antibiotic intake 
should be carefully recorded and taken into 
account in the data analysis. Other 
confounders include e.g. diet and genetic 
background. 
(Yatsunenko 
et al. 2012; 
Macfarlane 
2014; 
Dethlefsen 
and Relman 
2011) 
16S approach 16S rRNA gene copy number variation: 
Varied copy numbers of 16S rRNA genes can 
be present in the genomes of different strains 
and species, and more than one type of 16S 
rRNA gene sequence has also been reported to 
exist in some strains. Thus, 16S rRNA gene 
quantitation is only indicative of cell numbers 
(Sun et al. 
2013; 
Větrovský 
and 
Baldrian 
2013) 
Targeted regions: sequencing V1-V3 region 
has been found to generate higher richness 
than V3-V5, but less diversity within 
Bifidoacteriaceae. 
(Group 
2012; Huse 
et al. 2012) 
Sample 
collection 
Sample type Choose representative bacterial 
community: Microbiota differ in different 
body compartments. 
Table 1 and 
(Kuczynski 
et al. 2012) 
Homogeneity of stool sample: Microbiota 
composition, especially the low abundance 
taxa, can vary between the outside and inside 
of the stool i.e. between the liquid and particle-
form of the same feces. Therefore, it is 
important to homogenize the specimen. 
(Walker et 
al. 2008; 
Swidsinski 
et al. 2010) 
Storage Short-/long-term: The key is to avoid 
freeze-thawing cycles before DNA extraction, 
since these are detrimental for DNA integrity. 
Freezing may favor the extraction of DNA from 
Gram-positive bacteria. Long-term storage 
should be at -80˚C, but there is no golden 
standard for short-term storage 
(Thomas, 
Clark, and 
Doré 2015) 
Wet lab DNA extraction 
 
Cell lysis: Repeated bead beating is 
recommended to efficiently extract DNA from 
both Gram-negative and Gram-positive 
bacteria  
(Salonen et 
al. 2010; Yu 
and 
Morrison 
2004) 
Extraction kits: both manual extraction (Kennedy et 
??
methods and commercial kits have been used. 
Also (semi)-automated extraction devices have 
been used. The extraction method can 
influence the results. 
al. 2014) 
Libary 
preparation 
Primers for amplifying 16S rRNA gene: 
The match between so-called universal primers 
and bacterial target DNA can vary according to 
bacterial species. Therefore, it is recommended 
to use adequately degenerated primers. 
(Group 
2012; 
Kuczynski et 
al. 2012) 
Microarray and 
sequencing  
Cross-hybridization and sequencing 
errors: The cross-hybridization observed 
between incorrect combination between 
probes and non-target molecules, and 
chimeras formed during PCR amplification are 
the critical errors in microarray and 
sequencing, respectively. Corresponding 
bioinformatics tools are available for 
correcting these errors. 
(Schloss, 
Gevers, and 
Westcott 
2011; Koltai 
and 
Weingarten-
Baror 2008) 
Dry lab Pre-processing Quality control: Reference samples and/or 
spiked genes are always needed 
 
(Haas et al. 
2011; 
Reuter, 
Spacek, and 
Snyder 
2015) 
Sequence identification: There is a 
difference in using reference-based or de novo 
approach in the taxonomic assignment of 
sequence information. In a reference-based 
approach, a high quality database is required, 
such as SILVA and Greengenes. 
(Kuczynski 
et al. 2012) 
Sequencing depth: The number of reads 
obtained (library size) can vary extensively 
between samples, which can even be greater 
than any biological differences in some studies. 
Therefore, the normalization of the library size 
or controlling for its effect is necessary when 
comparing different samples  
(Gihring, 
Green, and 
Schadt 
2012) 
Statistical 
analysis 
Complex data and multiple 
comparisons: high throughput data are high 
dimensional, sparse and contain fewer samples 
than the number of variables. Therefore, on 
one hand, it is difficult to explore inter- and 
intra-individual variation. On the other hand, 
multiple comparisons introduce false positive 
p-values. 
(Tsilimigras 
and Fodor 
2016; 
Kuczynski et 
al. 2012) 
Wet lab qPCR validation Extracting health/disease-specific 
bacterial signature: 16S approaches are not 
accurate at the species/strain level. Therefore, 
high throughput analysis can be considered as 
a discovery tool and results usually need 
validation by qPCR especially for low 
abundance species/strain- level quantification. 
(Bacchetti 
De Gregoris 
et al. 2011) 
??
Characterization 
of 
health/disease-
specific bacterial 
isolates 
Translation between experimental 
models: The functional exploration of specific 
bacterial strains starts from in vitro studies, 
followed by controlled model systems, such as 
in vitro cell lines and ex vivo models and 
finally in vivo models/trials. The results from 
controlled systems and in vivo trials quite 
often differ from each other and therefore, 
model systems need to be constantly 
improved.  
(Bermudez-
Brito et al. 
2013) 
 
Although high-throughput methods, especially metagenomics are useful tools for 
characterizing genetic potential and compositional changes of the gut microbiota, 
this method can only deliver the potential functions of gut microbiota. Therefore, 
other omics-approaches are often applied to reveal in greater detail the activities of 
the microbial community at different functional levels. For example, meta-
transcriptomics/proteomics/bolomics, are holistic approaches which focus on gene 
expression, protein and metabolites of the microbiota respectively, as reviewed in  
Kolmeder and de Vos (2014). Once health/disease specific microbes, such as 
potential probiotics, have been discovered by HT approaches, candidate-bacteria 
should be verified by qPCR or isolated by culturing.Furthermore, since the 
properties of bacteria, including probiotics, are species/strain specific, the 
assessment of strain properties is mandatory in different controlled experimental 
model systems before proceeding to in vivo human interventions (Marteau 2011). 
In such studies, various in vitro cell lines, such as Caco 2 and HT 29 for epithelial 
interaction studies, ex vivo model systems and in vivo animal trials have been 
exploited (Bermudez-Brito et al. 2013; Tsilingiri and Rescigno 2012; Doron and 
Snydman 2015).  
Similarly, both targeted and holistic approaches have been applied in identifying 
health/disease specific host gene expression signatures in both clinical samples and 
experimental models. The reverse transcription polymerase chain reaction (RT-
PCR), is a fast and straightforward method for targeted (focused) analysis of 
specific genes, such as immune mediator molecules, or PRRs (Korpelainen et al. 
2014). Nowadays, it is still extensively applied, and even the expression level of 
specific gene can be identified, but selecting the specific genes to analyze the 
activation of different pathways is challenging. Therefore, omics-approaches such 
as RNA sequencing exhibit superiority in providing a holistic view and enabling also 
pathway analysis approaches (Korpelainen et al. 2014). A further challenge in 
analysing and interpreting host omics-data can be traced to the fact that clinical 
samples such as mucosal biopsies commonly contain mixed cell types. For example, 
both immune cells and enterocytes with different functions, as discussed previously 
in Section 2.1.2, may express the same PRRs.  
?
3.?AIM OF THE STUDY 
•? To compare the intestinal microbiota in healthy young children of 1–4 years 
of age to that as healthy adults (study I) 
•? To characterize the development and stability of intestinal microbiota in 
healthy pre-school age children (study II) 
•? To identify mucosa-associated microbial signatures and to explore the role of 
host-microbiota interactions in healthy and CeD children (study III)  
??
4.?MATERIALS AND METHODS 
4.1? Study subjects and samples 
The studies were approved by the University of North Carolina (UNC) Internal 
Review Board (I and II) (Fig. 9) and the ethical committee of the Hospital District 
of Southwest Finland (III). All adult subjects and guardians of the children 
provided consent. Notably, children with treated Celiac disease could not be 
included as a control group in study III, because in Finland, it is not permissible to 
perform an invasive sampling during esophagogastro-duodenoscopy in order to 
take follow-up biopsies from children, if their celiac serology has turned negative 
within two years after the GFD treatment. A summary table of study subjects in the 
cross-sectional studies I and III is provided in Table 8.  
The children in studies I and II represent a subset of subjects from a larger 
synbiotic intervention trial (ClinicalTrials.gov: NCT00653705) (Ringel-Kulka et al. 
2015). The baseline and follow-up samples of these children were used in studies I 
and II respectively. Study I is a cross-sectional study for the comparison of 
intestinal microbiota composition between children and adults from the same 
geographical region in US (Fig. 9). Study II focuses on the characterization of fecal 
microbiota development in children (Fig. 9).  
 
 
Figure 9. Design of the synbiotic intervention trial and samples used in studies I & II 
(modified from Fig. S1 in publication II). After sampling at baseline, the children were 
enrolled in a four-months synbiotic intervention trial. In synbiotic intervention group, the children 
took the product containing probiotic strain Bifidobacterium animalis subsp. lactis (BB-12), yogurt 
starter strains Streptococcus thermophilus and Lactobacillus bulgaricus, together with prebiotic 
inulin. While in placebo intervention group, the children drank acidified milk. The details are 
described in (Ringel-Kulka et al. 2015). Follow-up fecal samples were collected for 1 year, i.e. 
immediately after the intervention, and 2 and 8 months after the cessation of the intervention (Fig. 
9). Both children and adults had no history of antibiotic treatment in the previous 4 weeks before the 
intervention, and no history of probiotics consumption during the 2 weeks prior to the start of the 
intervention.  
???????????????
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4.2?Analytical methods 
Both fecal DNA (I & II) and duodenal tissue RNA/DNA (III) were studied. The 
methods used in the analysis are detailed in Tables 8-10. Briefly, the sample 
preparation, storage and RNA/DNA extraction followed previously described protocols 
(Carroll et al. 2011; Kalliomäki et al. 2012). Subsequently, the bacterial phylogenetic 
microarray HITChip was applied to produce microbiota profiles (I, II and III) (Rajilić-
Stojanović et al. 2009) with slightly modified protocols to deal with the specific types 
of samples (Table 9 & 10). Reverse transcriptase quantitative PCR (RT-qPCR) was used 
to study the host mucosal gene expression (III) (Table 10 & 11) as described previously 
(Kalliomäki et al. 2012). Data analysis were conducted using parametric or non-
parametric statistics for clinical data, intestinal microbiota and host gene expression 
analysis (I, II and III) (Table 11). The bioinformatic and statistical analysis were 
performed with R statistical software packages “stats”, “vegan”, “multcomp” and 
“nlme”. In addition, qPCR was used for quantitative analysis of specific bacterial taxa 
in study I (Table 9).  
HITChip is specifically designed for characterizing human intestinal microbiota 
diversity and composition (Rajilić-Stojanović et al. 2009). It utilizes approximately 
4,800 oligonucleotide probes targeting on 1038 bacterial phylotypes (<98% identity). 
Each phylotype is classified by multiple probes targeting the V1 and V6 hyper-variable 
regions of the 16S rRNA gene. These probes are categorized at three levels of 
specificity: level 1 (L1, phylum/order like sequence taxa), level 2 (L2, genus-like taxa, 
>90% similarity), and level 3 (L3, >98% similarity). The relative change of the 
hybridization signal of phylotype-specific probes has been shown to be directly 
proportional to the quantitative change of the respective phylotype in a complex 
ecosystem (Rajilic-Stojanovic et al., 2009). 
Table 9.   Methods used in the procedures of microbiota analysis in the thesis. 
Steps Method Study Reference 
Sample preparation 
DNA extraction 
 
Fecal DNA: Bead-beating integrated with 
phenol-chloroform for DNA extraction and 
Qiagen DNeasy blood and tissue extraction 
kit for DNA purification. 
I, II (Carroll et al. 
2011) 
Tissue DNA: Bead-beating integrated with 
Qiagen DNeasy blood and tissue extraction 
kit.  
III (Kalliomäki et 
al. 2012) 
DNA quality 
control 
NanoDrop ND-1000 spectrophotometer. I, II, 
III 
 
(Carroll et al. 
2011; 
Kalliomäki et al. 
2012) 
HITChip microbiota profiling 
Amplification of 
16S rRNA gene 
Fecal DNA: T7 prom-Bact-27- FOR and 
Uni-1492-REV primers, targeting on V1 to 
V9 regions in 16S rRNA gene  
I, II (Rajilić-
Stojanović et al. 
2009) 
 
??
???
Tissue DNA:  T7 prom-Bact-27- FOR and 
Uni-1369-REV primers, targeting on V1 to 
V8 regions in 16S rRNA gene  
III (Iwamoto et al. 
2000) 
In vitro 
transcription, 
dye labelling, 
fragmentation, 
hybridization 
PCR products were transcribed in vitro to 
RNA and labeled with dye Cy3 and Cy5, 
followed by fragmentation and 
hybridization. At least two samples from the 
same subject, each carrying one dye at a 
time, were hybridized to two different 
arrays until they passed the quality control 
and produced reproducible microarray 
profile. 
I, II, 
III 
(Rajilić-
Stojanović et al. 
2009) 
Extraction of 
intensity value 
Qualified by Agilent Feature Extraction 
software (version 10.7.3.1). 
I, II, 
III 
(Rajilić-
Stojanović et al. 
2009) 
Pre-processing 
Quality filtering 
 
 
Pearson correlation between technical 
replicates was determined by using an in 
house R script and coefficient 0.95 was used 
as the cut-off value for reproducibility. 
I, II (Lahti et al. 
2014) 
Pearson correlation coefficient 0.94 was 
used as the cut-off value for technical 
replicates of microarray profiles from 
duodenal biopsies. 
III (Lahti et al. 
2014) 
Between-
sample 
normalization 
in HITChip data 
Min-max algorithm. I, II, 
III 
(Han 2011; 
Bolstad et al. 
2003) 
Background 
signal 
subtraction in 
HITChip data 
The biological signal intensity was defined 
as 25% higher than the average value of 
signal intensity of 500 probes with the 
lowest signals. 
III (Rajilić-
Stojanović et al. 
2009) 
 
Phylogenetic characterization of microbial ecosystem 
Diversity Estimated by Simpson’s reciprocal index 
and Shannon indices on log10-transformed 
probe level data. 
I, II, 
III 
(Oksanen et al. 
2015) 
Richness Quantified by the number of responding 
oligos. 
II (Satokari et al. 
2014) 
Evenness Estimated by Pielou’s evenness index on 
log10-transformed probe level data. 
II (McCune and 
Grace 2002) 
Stability Estimated by Pearson’s correlation 
coefficient between consecutive sampling 
points on log10-transformed probe level 
data. 
II (Satokari et al. 
2014) 
Composition Estimated by summing the signal intensities 
for probes targeting a L1/L2 taxa.  
I, II, 
III 
(Jalanka-
Tuovinen et al. 
2011) 
???
Core microbiota 
at L2 
Core L2 HITChip bacterial taxa were 
defined as shared by at least 70% of the 
subjects with at least 0.1% relative 
abundance. 
II Study II 
 
Functional prediction of microbiota contents 
Butyrate-
producing 
bacteria  
Estimated by summarizing the relative 
abundances of 10 HITChip L2 taxa, which 
have been reported to be butyrate-
producing bacteria. 
II Study II 
MAMP 
prediction 
Estimated by summing up the bacterial 
abundance of G+, G-, or flagellated or high 
GC% L2 HITChip taxa. The relative 
abundance of these bacteria was used to 
reflect their corresponding MAMP ligand 
load. 
III 
 
Study III 
Validation of HITChip microarray result 
Bifidobacteriu
m spp. 
Performed in SYBR Green integrated qPCR, 
and quantified by normalizing to standard 
DNA.  
I 
 
 
(Bartosch et al. 
2004; Carroll et 
al. 2011) 
G?+:? Gram-positive bacteria; Gram-: Gram-negative bacteria; high-GC% bacteria: genomic GC% content 
is more than 58%. 
 
Table 10.   Methods used in host gene expression analysis. 
Steps Method Study Reference 
RNA stabilization 
 
RNAlater III (Kalliomäki et al. 
2012) 
 RNA extraction 
 
Qiagen RNeasy Plus Mini-kit III 
RNA quality control 
 
Bio-Rad Expression system III 
qRT-PCR Taqman gene expression assay III 
Quantification of gene 
expression data 
Relative changes as compared 
to endogenous control (18S 
RNA) 
III 
 
 
Table 11. Statistical methods used in data analysis. 
Steps Method Study Reference 
Clustering/classification Hierarchical clustering with 
complete linkage algorithm 
I (Legendre and 
Legendre 1998) 
???
Cross validation + Random 
forest 
III (Breiman Leo 
2001) 
Dimensionality 
reduction 
 
Principal component analysis I, III (Venables and 
Ripley 2003) 
Redundancy analysis I, III (Legendre and 
Legendre 1998) 
Data normality test Shapiro-Wilk normality test I, II, III (Royston 1995) 
 
Test of significance Parametric statistics: t-test, 
ANOVA, linear (mixed) model 
I, II, III (Chambers and 
Hastie 1991; 
Pinheiro, Bates, 
and R-core 2015) 
Non-parametric statistics: 
Wilcoxon rank-sum test, 
Kruskal-Wallis test 
II, III (Siegel and Jr 
1988) 
Permutation test on the 
constraints after redundancy 
analysis 
I, III (Legendre and 
Legendre 1998) 
P-value correction for 
multiple testing: Tukey’s 
Honest Significant Differences 
post-hoc analysis, Benjamini-
Hochberg false discovery rate 
correction 
I, II, III (Yandell 1997; 
Benjamini et al. 
2001) 
Correlation testing Spearman or Pearson 
correlation coefficient 
I, II, III (Chambers and 
Hastie 1991; Siegel 
and Jr 1988) 
 
5.?RESULTS AND DISCUSSION  
5.1? Age is the major determinant of fecal microbiota 
development of young children (Study I and II) 
The studies (I and II) examined the relationship between the effects of many variables, 
some of which might be confounding factors that should be controlled before one can 
draw any general conclusions in future observational clinical studies. As illustrated in 
Fig.9, the samples used in studies I and II were a subset from a 2-arm, randomized, 
double-blind and placebo-controlled trial but sampling biases were still present in 
gender, race, BMI category and BF or FF (Table 8) (Ringel-Kulka et al. 2015). 
Therefore, it was important to evaluate the potential confounding effects of these 
variables on microbiota in both the baseline and subsequent follow-up samples.  
We identified no significant effects of gender, race and BMI category on the structure 
of microbial community in either of our study cohorts (children or adults), as 
demonstrated by visual examination in PCA and no statistical difference by using 
permutation test on RDA analysed constraints (Fig. S2-S4/I, as referred to the 
???
Supplementary Figure 2-4 in publication I). Furthermore, no significant confounder 
effect was found at the bacterial genus-like level after applying linear regression 
models. Although in adults the abundance of several bacterial taxa was associated with 
gender, race and BMI category, the abundance of these particular taxa was not 
significantly different between children and adults (Table 1/I). In addition, no 
correlation was found between the history or duration of BF and the abundances of the 
bacterial genus-like level taxa in children, including bifidobacteria (study I). These 
results suggested that the confounding effects of the above mentioned variables were 
minimal in the data. 
In the longitudinal study II, the effects of the synbiotic supplements, occasional 
antibiotic courses, zBMI and age were estimated by linear mixed effect models. Except 
for age, the other factors had no or only a minor effect on the overall microbiota 
profiles except for several specific phylum-level bacterial taxa (Table S5/II). 
The synbiotic supplement was found to exert a minor effect on fecal microbiota in the 
intervention group i.e. it only increased the stability of one phylum-like taxa i.e. 
Actinobacteria, out of a total of the 22 phylum-like taxa present in the samples. The 
limited response in the overall structure of fecal microbiota is in agreement with the 
previous observations in several probiotic intervention studies conducted in both 
children and adults (Gerritsen et al. 2011; Kim et al. 2013; Lahti et al. 2013). The 
increased stability of Actinobacteria is likely due to inulin, as it is known that inulin 
supports the growth of bifidobacteria which is the main taxa within the Actinobacteria 
phylum in the intestine (Salazar et al. 2015; Veereman 2007). 
The relative abundance of Clostridium cluster XIVa was found to be reduced by 
antibiotics in the first sample taken after the course (LME P=0.02, Fig. S2/II). In 
addition, the stability of the Clostridium cluster I was reduced by the use of antibiotics. 
These results are consistent with previous studies where antibiotics was found to 
reduce microbiota stability and diversity (Rehman et al. 2012; Panda et al. 2014). 
However, the abundance of Clostridium cluster XIVa was not significantly lower in the 
subsequent follow-up samples as compared to the baseline samples. This indicates that 
after the cessation of antibiotic therapy in study II, which are penicillin-type antibiotics, 
the Clostridium cluster XIVa had partially recovered from a lower level of abundance 
after the antibiotic course (Fig. S2b/II). Unlike the long term effect of macrolides, 
which have wider spectrum than penicillin, the penicillin-type antibiotics including 
amoxicillin have been reported to exert a weaker effect on both overall microbial 
richness and specific microbiota abundance (Korpela et al. 2016). Furthermore, even 
with repeated administrations of penicillin, no significant reduction in richness was 
found at six months after the treatment (Korpela et al. 2016). Therefore, a single 
antibiotic course using amoxicillin produced only temporary effect as a partial recovery 
eventually occurred within weeks or months. The effects of synbiotic consumption and 
antibiotics were considered as covariates when estimating the temporal development 
of microbiota. 
???
5.2? Comparison of fecal microbiota composition in healthy 
Western young children and adults (Study I) 
5.2.1? Similarities of microbiota composition between children and adults 
When comparing the fecal microbiota composition in healthy young US children 
(denoted as group C) and adults (denoted as group A), similarities for certain bacterial 
taxa were found at both phylum-like and genus-like levels. Firmicutes (C:80.67%, 
A:81.12%), Bacteroidetes (C:5%, A:13%) and Actinobacteria (C:12.5%, A:3.4%) were 
observed to be the most predominant phyla in both age groups. Previously, similar 
findings have been reported i.e. that Firmicutes and Bacteroidetes are the major 
bacterial taxa of intestinal microbiota in both children and adults (Yatsunenko et al. 
2012; Eckburg et al. 2005). 
Phylogenetically, Firmicutes contains a broad range of genera; these are often divided 
into phylogenetic sub-groups, which have also distinctive functional characteristics. 
For example, Clostridium clusters IV and XIVa contain butyrate-producers (Duncan et 
al. 2002). Clostridium cluster XIVa was found to be the most predominant taxa in both 
the children and adult groups, with almost equal abundances (50.4% vs. 54.9% 
respectively; p?=?0.37), suggesting that this phylum may have already been stabilized at 
an early age i.e. before 4 years of age. The early establishment of the Clostridium 
cluster XIVa was further supported by the observation that 18 out of 19 Clostridium 
cluster XIVa genus-like taxa did not differ significantly in their relative abundance 
between children and adults. Ruminococcus obeum et rel. was noted as the most 
predominant genus-like taxa in both adults and children, with the same level of relative 
abundance (11.6% in A and 13.9% in C; p>0.05). The trend of Clostridium cluster XIVa 
was further explored in more detail in study II, by dividing the children into different 
age categories to assess their microbiota development; these results will be discussed 
later in Section 5.3.1.  
 
5.2.2?Dissimilarities of microbial composition between children and 
adults  
At the genus-like level, the structure of the fecal microbiota community in healthy US 
children aged 1-4 years old was significantly different from that of adults from the 
same geographic region as revealed by both unsupervised PCA and supervised RDA 
(p?=?0.003) analyses. The community level differences between children and adults 
were further highlighted by significant differences in relative abundances of 26 genus-
like bacterial taxa, which all had a relative abundance of at least 0.01% of the total 
bacterial population and thus, can be considered as major taxa within the ecosystem. 
Notably, significantly higher levels of bifidobacteria were detected in children by both 
microarray analysis (C:11% versus A:3%, p?=?0.00008) and qPCR (2.7-fold higher 
abundance, p< 0.006). In contrast to some previous reports that the children in the US 
may lack bifidobacteria (Palmer et al. 2007), our study showed that higher levels of 
bifidobacteria were present also in the US children, similar to the  situation in 
European and Japanese children reported previously (Adlerberth and Wold 2009).  
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Five phylum-like bacterial taxa displayed significant differences between children and 
adults. For example, children in general had a higher abundance of Bacilli, which 
contains three predominant genera, Streptococcus bovis, S. mitis and S. intermedius et 
rel. (Table 1/I). On the other hand, Clostridium cluster IV had a higher relative 
abundance in adults than in young children (24% vs. 16% respectively; p?=?0.02). 
Furthermore, all dominant genus-like level taxa within the Clostridium cluster IV 
consistently exhibited either equal or higher abundance in adults. However, all the 
bacterial taxa within this phylum-like level taxa showed very high variability in terms 
of the relative abundance between the individuals of the same age, with F. prausnitzii 
et rel being the most variable taxa in young children (data not shown). These findings 
indicate that the microbial compositional transformation within Clostridium cluster IV 
has not yet reached its ultimate level in young children. Similarly, Bacteroidetes 
showed a significantly higher abundance in adults than in children (A: 13% vs. C: 4.7%, 
p=?0.02). Adults had a range of 2.4–6.3-fold higher abundance of all dominant genus-
like level taxa within this phylum than children. Similar to F. prausnitzii et rel, all of 
the taxa in Bacteroidetes displayed high variance in terms of abundance in both 
children and adults. Actinobacteria were observed to be the third most abundant 
phylum-like level taxa in children, while being significantly less abundant than in 
adults (A: 3.4% vs C: 12.5%, p<0.01). More detailed development patterns of these 
major phyla were characterized in study II in an attempt to gain a better understanding 
of their early establishment. 
 
5.3? Characterization of fecal microbiota development in 1-5-
year old children (Study II) 
5.3.1? Temporal stability and resilience 
Intestinal microbiota is less diverse up to 5 years of age than in adults 
No change in microbiota diversity was observed in children from approximately 1 to 5 
years of age. Moreover, the microbiota diversity measured at the HITChip oligo level 
was significantly lower in all age categories (1-2Y, 2-3Y, 3-4Y, 4-5Y) of children as 
compared to adults (Fig. 5/I and Fig. 1/II, p<0.01). It was shown that microbiota 
diversity, including richness and evenness, underwent fluctuations when the children 
were 1–5 years of age, and it had not yet reach its zenith by the age of 5 years (Fig. 1/II). 
These results contrast the recent findings that microbial diversity of children in United 
States has progressed to a similar level than in adults by the age of three years 
(Yatsunenko et al. 2012; Schloss et al. 2014). Furthermore, these US children harbour 
a less diverse microbiota in comparison to their counterparts from developing 
countries in South America and Africa (Yatsunenko et al. 2012). We hypothesized that 
the Western lifestyle with its excessively hygienic conditions, diet and the use of 
antibiotics may influence the diversification of intestinal microbiota in infants and 
young children. Recently, this hypothesis was tested in mice fed with either a Western 
diet (high in fat and simple carbohydrates, low in fibre) or a more traditional diet 
containing a high proportion of fibre (Sonnenburg et al. 2016). The consumption of the 
Western diet was found to result in a less diverse microbiota, especially the lost taxa in 
Bacteroidales, which is the fibre-utilizing order. The loss of diversity was further 
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shown to be restored within a single generation if the animals were provided with the 
traditional diet, but it became irreversible after several generations with the same diet 
i.e. there was a permanent loss of microbial taxa that are passed on from one 
generation to the next (Sonnenburg et al. 2016). Therefore, two scenarios can be 
considered for Western children; they may either develop a more diverse microbiota 
later in life or their microbiota might unlikely reach the same level of diversity to that 
of earlier generations due to the permanent loss of certain microbial taxa, such as 
Bacteroidales, which has taken place over several generations.  
Major phyla undergo gradual transformation from 1 to 5 years of age 
Although no change was found in bacterial diversity in children from 1 to 5 years of age 
(Fig. 1/II), a gradual transformation of microbiota was observed as the stability of the 
overall bacterial community increased with age (p=0.03 in LME, Fig.2/II). Further, 
discordant phyla development, with different microbial abundance and stability from 
children towards adults was detected, as shown in Table 12.  
Although the stability of overall microbiota profile increased from 1 to 5 years of age 
(Fig. 2/II), it was still remarkably lower than that previously observed for Western 
adults as investigated with the same microarray technique (Jalanka-Tuovinen et al. 
2011; Rajilić-Stojanović et al. 2012; Fuentes et al. 2014; Satokari et al. 2014). 
Furthermore, we found heterogeneity in the stability of different phylum-like level taxa 
(Fig. 4/II, Table 12). For example, Clostridium clusters XIVa has temporally unstable 
profiles, although it is the most abundant phylum-level taxa and has already been 
established at 1-2Y. In contrast, although Clostridium clusters IV has temporally 
unstable profiles as well, its abundance is still increasing from 1 to 5 years of age. The 
increase of stability of these bacterial taxa was not obvious, suggesting that Firmicutes 
might be in the process of rearrangement in children and that the phylum is expected 
to reach a mature status only at a later age. On the contrary, the other major phyla 
including Actinobacteria, Bacteroidetes and Proteobacteria had higher stability than 
Clostridium clusters in children. Interestingly, we found that Bacteroidetes, more 
specifically Bacteroides spp. was the only phylum that invariably showed increasing 
stability from 1 to 5 years of age (Fig. 5c/II, p=0.04), suggesting that Bacteroidetes 
might be the main driver of microbiota stability toward an established individual-
specific microbiota assembly from infancy to adulthood. Our results are in line with a 
previous study conducted on a Swedish cohort, where the process of microbiota 
maturation was also observed to proceed beyond 1-2 years of age (Bäckhed et al. 2015). 
On the other hand, we found that Clostridium cluster XIVa and Proteobacteria had 
reached an adult-like abundance level already by 1–2 years of age (Table 12). This 
observation is more consistent with the conventional view that intestinal microbiota 
usually becomes adult-like within the first 3 years of life (Yatsunenko et al. 2012). Thus 
far, most studies have been cross-sectional focusing on the abundance of bacterial taxa. 
Our longitudinal data demonstrates that stability should be also assessed to gain an 
evolutionary understanding. The establishment of Clostridium cluster XIVa at high 
abundance at an early age highlights the importance of these bacterial taxa in the 
symbiotic relationship between the human host and the intestinal microbiota. On the 
other hand, it might indicate that diet already in toddler age provides stable amount of 
nutrients utilized by Clostridium cluster XIVa. Overall, we concluded that major 
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intestinal phyla are in the process of developing into an adult-type composition at an 
individualized pace, and the overall duration of microbiota maturation seems to take 
up more than 5 years. 
 
Table 12. Summary of the temporal development of different phylum-level bacterial taxa 
from 1 to 5 years of age (modified from Table 1 in publication II) 
Phylum-level taxa Relative abundance at 
1-2y vs. adults 
Change in relative 
abundance 1-5y 
Stability* at 1-5y Overall status  
Actinobacteria Higher No change High, no change Child-like, stable 
Bacilli Higher No change High, no change  Child-like, stable 
Bacteroidetes No difference No change Moderate, increase Developing 
Clostridium 
cluster I 
Higher No change Moderate, no change Child-like, relatively stable 
Clostridium 
cluster III 
Lower Increase High, no change Developing 
Clostridium 
cluster IV 
Lower Increase tendency Low, no change Child-like, unstable 
Clostridium 
cluster XI 
No difference Increase Moderate, increase 
tendency 
Developing 
Clostridium 
cluster XIVa 
No difference No change Low, no change Adult-like, unstable 
Proteobacteria No difference No change Moderate, no change Adult-like, relatively stable 
Abbreviations: y, years 
*Stability was assessed as Pearson correlation of oligoprofiles between consecutive time points 
 
Previously, higher levels of bifidobacteria have been found in infants in comparison to 
adults (Roger et al. 2010; Arrieta et al. 2014; Bergström et al. 2014). In our study, we 
showed that bifidobacteria had a higher abundance in children aged 1-2 years than in 
adults (p<0.01, study I and II) and moreover, that this kind of child-like abundance 
level did not change significantly from 2 to 5 years. As discussed in Section 5.1.2, 
synbiotic intervention exerts limited effect in the study cohort and it could not explain 
the elevated levels of bifidobacteria. In a recent Danish study, Bifidobacterium spp. 
was decreased from 9 months to 3 years of age, which might due to the cessation of 
breastfeeding at 9 to 18 months (Bergström et al. 2014). On the other hand, another 
study using a microarray technique to assess microbiota in adolescents reported that 
the adolescent group showed higher (nearly two-fold) levels of Bifidobacterium spp. 
compared to the adult group (9% vs, 5.4% respectively; p<0.01), pointing to decrease 
of bifidobacteria from adolescents to adult (Agans et al. 2011). The intermediate level 
of relative abundance in adolescents as compared to that in young children (11%) and 
adults (3% and 5.4%) may suggest a gradual decrease in Bifidobacterium spp. levels 
starting from infancy to adulthood. This decrease in Bifidobacterium spp. abundance 
might persistent after adulthood to death, since lower abundance of Bifidobacterium 
spp. was observed in elderly than adults (Claesson et al. 2011). The findings by Agans 
et al (Agans et al. 2011) are in line with our observation that in childhood, the intestinal 
microbiota is not yet assembled in an adult-type manner. Bifidobacterium spp. are 
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generally considered as important candidates for probiotic strains, as several studies 
have suggested that they may exert health-promoting functions e.g. by strengthening 
epithelial integrity and having anti-inflammatory properties (Jungersen et al. 2014; 
Hsieh et al. 2015). Furthermore, bifidobacteria can cross-feed butyrate producing 
bacteria by acting as primary degraders, which partially hydrolyze polysaccharides 
which then act as the secondary substrates for the butyrate-producing bacteria (De 
Vuyst and Leroy 2011).   
Analysis of children categorized into different age groups revealed differences also in 
the levels of inter-individual similarity. We found that the inter-individual similarity 
peaked at 3-4 years of age in our study cohort, while lowest in adults (Fig. S7/II), 
suggesting a more similar microbiota within this age group. The result may reflect the 
longer consumptions of standardized meals and longer exposure to the overall similar 
microbial environment in a daycare center of the older children as compared to their 
younger counterparts. This concept is supported by the observation that diet and 
environment may affect the gut microbiota shortly after institutionalization such as in 
daycare or healthcare centers (Claesson et al. 2012). 
 
5.3.2? Emergence of core microbiota 
The core microbiota has been investigated in adults in order to reveal major bacterial 
taxa in subjects beyond their individuality (Sekelja et al. 2011; Huse et al. 2012; 
Turnbaugh et al. 2009). The development and establishment of the core microbiota 
starting from infancy have remained largely unknown. In study II, the core microbiota 
of children was investigated and compared to that of adults. We found that a common 
core, comprising of 18-25 genus-like taxa belonging to Actinobacteria, Bacilli, 
Clostridium clusters IV and XIVa constituted more than 70% of the total microbiota 
with a stable level of abundance in all age categories of children and adults (Fig. 10; 
Fig. S8/II). We further determined the timeline of the emergence of the core 
microbiota and found that the assembly of the core microbiota may have started 
already at 1 year of age. The expansion of the core microbiota from infancy to 
adulthood was observed with the increased number of genus-level taxa, from 18 in 1-2-
year-old children to adults aged 25 respectively. This dynamic development was also 
reported in a recent study, although it described a much larger core consisting of 49 
genera in 1-year old infants (Vallès et al. 2014).  The smaller size of core microbiota in 
our study might be due to the more stringent filtering process of the genus-like taxa, 
i.e. we applied a threshold of >0.1% of relative abundance and >70% prevalence to 
filter out the unrepresentative taxa. The composition of the core microbiota was not 
static, as we found that Bifidobacterium, Streptoccus mitis et rel. and Streptococcus 
bovis et rel. in the children core were finally taken up by Oscillospira guillermondii et 
rel., Butyrivibrio crossotus et rel. and Clostridium stercorarium et rel. in adults 
(Fig.10). Our results provide evidence for the start of the early establishment of a core 
microbiota, which holds the possibility of compositional changes in the assembly of 
core microbiota due to environmental factors and physiological changes after 
childhood. 
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Notably, we found that butyrate-producing bacteria increased steadily in their relative 
abundance to the adult-like level before 5 years of age (p=0.02, study II). A recent 
nutritional study reported >30% increase of absolute intakes of protein, fibre during 
the first two years of life (Lioret et al. 2013). Therefore, the increasing level of butyrate-
producing bacteria might due to increasing fibre intake. Furthermore, bacterial taxa 
producing butyrate were also increased in the children’s core microbiota (Fig. 10). This 
was interpreted as evidence of the ongoing diversification of this essential functional 
taxa in healthy children. Butyrate-producing bacteria provide butyrate as the major 
energy source for enterocytes and thus they support the mucosal physiology by 
stimulating motility, mucous secretion, sodium and water absorption, as well as 
regulating epithelial barrier and immunity functions of the IECs (Leonel and Alvarez-
Leite 2012). Recently, Jalanka et al. (2016) reported a therapeutic microbiota core that 
could explain the treatment efficacy of fecal microbiota transplantation for recurrent 
Clostridium difficile infection in adults. Interestingly, the bacterial taxa included in 
this therapeutic core have 64% overlap with the healthy adult core microbiota in study 
II. Importantly, six out of eight butyrate producers that were included in the core in 
study II were also present in the therapeutic core defined by Jalanka et al. (2016). This 
concurrence indicates that core microbiota and specific taxa therein can be considered 
as keystone members for maintaining intestinal homeostasis and host health.  
 
 
Figure 10. The development of core microbiota (adapted from Fig. 6 in publication II). 
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5.4?Duodenal mucosal homeostasis in celiac disease and 
healthy children (Study III) 
5.4.1? Microbiota profiles of duodenal mucosa 
In study III, we investigated the microbiota profiles in duodenal mucosa in HC and 
CeD children as well as explored host-microbe interactions by examining the mucosal 
gene expression and. Altogether 13 phylum-like and 65 genus-like taxa were detected 
in healthy duodenal mucosal biopsies (Table 1/III), which is substantially fewer than 
the number previously observed in fecal samples in a pediatric population analyzed 
with the same profiling platform i.e. 22 and 130 phylum- and genus-like level taxa 
respectively (study I and II). The major phylum-like level taxa in duodenal biopsies 
were Proteobacteria, Bacilli, Bacteroidetes and Clostridium cluster XIVa (Fig. 2/III). 
The predominant genus-like level taxa were Sutterella wadsworthensis et rel., 
Streptococcus mitis et rel., Aquabacterium, Streptococcus bovis et rel., Streptococcus 
intermedius et rel., and Prevotella melaninogenica et rel. Notably, the genus 
Streptococcus accounted for about 30% of the total duodenal microbiota in HC 
subjects, suggesting a major contribution of streptococci in the small intestinal 
microbiota, which has been observed previously in ileostomy samples in adults 
(Zoetendal et al. 2012; Sullivan et al. 2003). Furthermore, S. wadsworthensis et rel. 
was detected as the most abundant genus-like taxa within Proteobacteria, in line with 
previous findings in human mucosal samples in both pediatric and adult populations 
(Mukhopadhya et al. 2011; Hansen et al. 2013).  It has been suggested that Sutterella 
spp. might play a role in the pathogenesis of IBD, autism, Down syndrome and 
metabolic syndrome (Williams et al. 2011; Biagi et al. 2014; Lim et al. 2016; Hansen et 
al. 2013), while other studies do not provide supporting evidence for this hypothesis 
(Mukhopadhya et al. 2011; Son et al. 2015). In a recent study, the interaction of three 
Sutterella species with intestinal epithelium was examined in vitro, and the results 
suggested Sutterella spp. to be mutualistic i.e. it was thought to maintain the immune 
system in an alert-state, like other commensals, but not to evoke a strong inflammatory 
reaction (Hippala et al. 2016).   
 
5.4.2?Health- and celiac disease associated microbial signatures 
The phylum- and genus-like bacterial compositions, and total bacterial diversity in 
duodenal mucosa were similar between the HC and CeD groups (Table 13). 
Furthermore, the microbial community structures were not separated between HC and 
CeD subjects, as revealed by using PCA and RDA analyses (Table 12, Fig. 11, and Fig. 
S1-2/III). In this study, no significant difference in single bacterial abundance is 
consistent with previous observations, which have compared duodenal microbiota in 
HC and CeD subjects (Ou et al. 2009; Kalliomäki et al. 2012). However, in contrast to 
our results, microbial dysbiosis with increased level of facultative anaerobes to obligate 
anaerobes, and/or elevated microbial diversity and total bacterial counts (Nadal et a. 
2007; Schippa et al. 2010) have been reported in the duodenal mucosa in active CeD 
children in comparison to their HC counterparts. These altered bacterial taxa in CeD 
children are higher levels of Staphylococcus and Proteobacteria, particularly E.coli 
(Nadal et al. 2007; Collado et al. 2009; Sánchez et al. 2013) and increased Bacteroides 
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with decreased bifidobacteria (Nadal et al. 2007; Collado et al. 2009). Thus, some 
evidence exists both in support and against the possibility of microbiota dysbiosis in 
CeD. In an attempt to understand the collective interactions between bacterial taxa, a 
random forest prediction model was implemented to extract several genus-like taxa 
contributing to the separation of HC and CeD (Table 13, Table 1/III). For example, P. 
melaninogenica et rel., Haemophilus spp. and Serratia spp. had higher relative 
abundances in CeD compared to HC, while the other five bacterial taxa were more 
abundant in HC samples (Table 13). The functional relevance of these bacterial taxa in 
the differentiation of CeD from HC remains unknown and may be worthy of 
investigation in follow-up studies. It is still unclear, whether the possible microbiota 
changes detected in CeD are primary and contribute to the pathology of the disease or 
alternatively, the changes may occur as a consequence of the disease. Thus far, 
longitudinal microbiota data has been unable to reveal a possible link between 
microbiota composition including specific members within the microbiota and the 
disease development.  
It has to be taken into account that CeD profoundly affects the morphology, physiology 
and immunology of the small intestinal epithelium, and this represents a completely 
different ecological niche for bacteria as compared to a normal healthy mucosa. 
Furthermore, the possibility that microbes are involved in the etiology is also 
supported by the association found between infections and the risk of developing CeD 
(Plot and Amital 2009; Verdu et al. 2007). In this respect, both bacterial and viral 
infections have been suspected, such as Campylobacter jejuni (Verdu et al. 2007), 
Adenovirus 12 and Hepatitis C virus (Plot and Amital 2009). Therefore, further studies 
focusing on explaoring functional contents of all microbes, including virus are 
warranted to clarify the role of microbiota in CeD. 
Table 13. Summary of key findings in the duodenal samples in study III. 
 CeD vs. HC  TCeD vs. HC 
Microbiota No difference in overall microbiota community 
No difference in the abundance of single 
bacterial taxa 
No difference in bacterial diversity 
No difference in the estimated microbial ligand 
(MAMP) content for TLRs  
A sub-group of bacteria separate CeD and HC: 
HC: Prevotella oralis et rel. ?, Proteus et rel. 
?, Clostridium stercorarium et rel. ?, 
Ruminococcus bromii et rel. ?, Papillibacter 
cinnamivorans et rel. ? 
CeD: Prevotella melaninogenia et rel. ?, 
Haemophilus?, Serratia? 
No data 
Expression of tight 
junction proteins and 
immune-associated 
genes 
HC: positive correlation between ZO-1 and 
TLR2, IL-10/IFN-γ ?, TLR2?, Tollip? 
CeD: CXCR6 ?, IL-10?, IFN-γ?, IL-8?, 
TLR9? 
TCeD: CXCR6?, 
IFN-γ? 
HC: IL-10/IFN-γ ?, 
TLR2? 
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5.4.3?Dys-regulated host-microbiota interaction 
Microbes can be stratified by their ligand specificity (so-called MAMP content, see 
Section 2.1.2), which is recognized by host immune cells or IECs, i.e. they play a role 
especially in the innate immune response.  Similar to our result on microbiota profiles, 
no significant differences were found in the general MAMP content between HC and 
CeD subjects, suggesting that there is an overall similarity in the bacterial ligand loads.  
It has been reported that TLR signaling can affect epithelial barrier function through 
the expression of TJ proteins, gap junction proteins, MUC2 proteins and antimicrobial 
peptides such as RegIIIγ (Verdu et al. 2007; Ey et al. 2009). Specifically, in vitro 
stimulation of IECs by TLR2 has been characterized by an increased level of Cx43 
synthesis (a marker for gap junction proteins), an apical re-organization of ZO-1 (a 
marker for TJ proteins) and trans-epithelial resistance, which reflects the strength of 
tight junctions between IECs and barrier function (Cario, Gerken, and Podolsky 2004; 
Cario, Gerken, and Podolsky 2007; Ey et al. 2009) 
As previously reported for the same subjects, the expression of TLR2 was significantly 
reduced in both CeD and TCeD subjects when they were compared to HC (Kalliomäki 
et al. 2012). In addition, the downregulation of Tollip protein, the regulator of TLRs 
was observed in CeD as compared to HC (Kalliomäki et al. 2012). The expressions of 
TLR9 and IL-8, a marker of intestinal inflammation, were also found to be increased in 
CeD (Kalliomäki et al. 2012). TLR2 is expressed in both immune cells and IECs; this 
could be demonstrated via the LTA content of specific microbes (Abreu 2010). We 
found similar LTA contents, as assessed by the proportion of Gram-positive bacteria in 
the microbiota, between HC and CeD (Table 13, Table 1/III). Therefore, the net 
signaling through TLR2 might be increased in HC. Furthermore, the ZO-1 expression 
correlated positively with the level of TLR2 expression in the HC group (p?=?0.02, 
rho?=?0.88, Table 13, Fig. 5/III), supporting an earlier finding, which demonstrated 
that the epithelial barrier was more permeable in CeD subjects as compared to HC due 
to the decreased expression of tight junction proteins (Pizzuti et al. 2004). In our 
study, although no differences in the levels of expressions of proteins ZO-1 and Cx43 
were detected between CeD and HC (Table A2/III), significantly lower ZO-1 expression 
was found in CeD in comparison to TCeD (Fig. 5/III). The only correlation that was 
found between the abundance of bacterial taxa and expression of the studied host 
genes was the negative correlation between S. moorei et rel. and the expression of Cx43 
protein. However, no difference of S. moorei et rel. was found in the abundance 
between CeD and HC. Also the expression of Cx43 did not differ between CeD and HC. 
Thus, S. moorei does not seem to be associated specifically with CeD, but the result 
implies that S. moorei may affect intestinal barrier, which could be studied further by 
using in vitro models. 
As discussed in Section 2.3.3, alterations of both microbiota and the expression of host 
receptors recognizaing bacteria might involve in the pathogenesis of celiac disease, 
even though no conclusive microbial signatures have been reported thus far. CXCL16 is 
an important scavenger receptor in APCs for mediating phagocytosis of bacteria and it 
is a critical chemokine in leukocyte trafficking when there is inflammation (Darash-
Yahana et al. 2009; Shimaoka et al. 2003; Uza et al. 2011). Specifically, the co-
expression of CXCL16 and its receptor CXCR6 in natural killer T cells and Th1-
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polarized CD4 T cells has been implicated in IBD-associated inflammation (Uza et al. 
2011). In our study, the expression level of the cytokine, CXCL16, was found to be 
similar in CeD, TCeD and HC, whereas the expression of its receptor CXCR6 was 
higher in CeD and TCeD as compared to HC. CXCL16 has dual functions being a 
transmembrane adhesion molecule and a soluble chemokine (Abel et al. 2004). Both 
the membrane-bound forms of CXCL16 and its receptor CXCR6 have been found to be 
expressed not only in dendritic cells and macrophages and T cells respectively, but also 
in IECs (Abel et al. 2004; Hase et al. 2006; Diegelmann et al. 2010). Previously, 
increased intestinal CXCL16 expression has been observed in the colonic biopsies of 
Crohn´s disease patients due to immune cell infiltration (Diegelmann et al. 2010). In 
study III, an increased expression of CXCR6 was observed not only in the inflamed 
mucosa of CeD but also in TCeD without immune cell infiltration, suggesting that the 
increase level of CXCR6 originated from epithelial cells. However, the contribution of 
mucosa associated immune cells to the increased expression of CXCR6 could not be 
excluded as whole biopsies consist of many different cell types. The CXCL16-CXCR6 
chemokine-receptor systems has been shown to activate several distinctive signaling 
pathways in IEC, contributing to the integrity of epithelium through the regulation of 
mucosal innate and adaptive immune systems (Diegelmann et al. 2010). These are the 
first results demonstrating an increased duodenal expression of CXCR6 in CeD 
subjects, evidence of the important role of CXCL16-CXCR6 for mucosal immunity also 
in small intestine of CeD subjects. 
The high GC content of a bacterial genome correlates with a higher number of 
potentially immunostimulatory CpG motifs in the genome, which are ligands for TLR9 
in immune cells and IEC (Kant et al. 2014). Therefore, the GC content reflects the load 
of TLR9 ligands in the microbiota. The average genomic GC content (GC%) of the total 
microbiota, as well as the proportion of high-GC% bacteria was found to be comparable 
between the HC and CeD groups (Table 13, Table 1/III). Consequently, HC and CeD 
subjects are likely to harbor similar loads of TLR9 ligands. Therefore, the higher 
expression of TLR9 found in the previous study using the same cohort in CeD might 
reflect an increased net signaling through TLR9. In immune cells, TLR9 stimulation is 
known to trigger Th1-proned immune responses (Krieg 2002; Yu et al. 2007). 
Furthermore, an in vitro study demonstrated that apical TLR9 stimulation of IECs led 
to an increased expression of IFN-γ and IL-10, but not TNF-α from peripheral blood 
mononuclear cells (PBMCs) on the basolateral side of the cell membrane (de Kivit et al. 
2011). In our CeD patients, increased mucosal expressions of IL-10 and IFN-γ were 
also observed (Fig. 7/III). IL-10 and IFN-γ have been associated with the activity of 
gliadin-reactive T-cells after gluten/gliadin stimulation both in vivo and in vitro 
(Forsberg et al. 2002; Salvati et al. 2005; Gianfrani et al. 2006; Nilsen et al. 1995; 
Nilsen et al. 1998). We found that the expression levels of IFN-γ in the duodenal 
mucosa were increased also in TCeD subjects adhering to a gluten-free diet as 
compared to HC (Table 13, Fig. 7/III), indicating that there must be an additional 
gluten/gliadin-independent route of stimulation. Similarly to previous studies (de Kivit 
et al. 2011; Nilsen et al. 1995; Nilsen et al. 1998), TNF-α expression was found to be 
unaffected in CeD and TCeD as compared to HC. The ratio of IL-10 to IFN-γ 
transcripts was clearly reduced in both CeD and TCeD patients as compared to HC 
(Table 13, Fig. 7/III), suggesting that although IL-10 expression is increased there is 
still a significant inclination towards a Th1 response in both untreated and treated CeD 
???
patients. In conclusion, based on our results, I hypothesize that TLR9 signalling in the 
small intestine may contribute to the persistent activation of Th1 signalling pathway in 
CeD, as indicated by the increased levels of IFN-γ found in the CeD children even 
though they were consuming a gluten-free diet (Lahdenperä et al. 2011). The 
mechanisms of TLR9 signalling pathway might be mediated via the direct stimulation 
of immune cells and/or IECs.  
Optimally, the same group of patients, before and after GFD (TCeD) or a control group 
of pediatric TCeD patients would have been included in the study. In study III, a 
control group of pediatric TCeD could not be included, because in Finland follow-up 
biopsies are not taken from children after the implementation of GFD, if the treatment 
has been effective. CeD children and TCeD adults are likely to have differences in their 
microbiota composition also due to the age (Nistal et al. 2012; Cucchiara et al. 2009), 
and microbiota can influence the physiological status of the host including epithelial 
gene expression (Maynard et al. 2012; Wells et al. 2011). However, we found that the 
expression of a number of mucosa-associated genes, TLR2, TLR9 (Kalliomäki et al. 
2012), CXCR6, IL-10 and IFN-γ (study III) were increased in both CeD children and 
TCeD adults as compared to HC children. Thus, the altered expression of these genes 
may be intrinsic to CeD and independent of the age and microbiota composition.  
The strengths of this study are the comprehensive microbiota analysis by high 
throughput bacterial phylogenetic microarray, the use duodenal biopsies (and not 
feces) to study microbiota changes in CeD, which primarily affects the small intestinal 
mucosa and the gene expression analysis from the same individuals, which allows the 
assessment of correlations between microbiota and expression of relevant mucosa-
associated genes. The weaknesses of this study are the small study groups and the 
inability to include TCeD children as a comparison group for ethical reasons explained 
above. Thus far, duodenal mucosa-associated microbiota in pediatric CeD has been 
studied from biopsies of 168 active CeD, 103 TCeD and 90 HC children (Nadal et al. 
2007; Collado et al. 2009; Ou et al. 2009; Schippa et al. 2010; c; Di Cagno et al. 2011; 
Kalliomäki et al. 2012; Nistal et al. 2012; Sánchez et al. 2013), but only three studies 
have utilized a high throughput technique (pyrosequencing) to comprehensively assess 
the duodenal mucosal microbiota (Nistal et al. 2012; Sánchez et al. 2013). Although the 
study groups in the present work are small, our results from high-throughput 
microbiota profiling, like the results by Nistal et al. (2012) and Sánchez et al. (2013), 
give a more in depth view of the duodenal microbiota regarding the bacterial groups 
inhabiting duodenal mucosa and the overall diversity and underline the need to for 
further studies in order to improve the current understanding on possible links 
between microbiota and pediatric CeD. 
 
6.?CONCLUSION AND FUTURE PERSPECTIVES 
In studies I and II, as compared to adults a less diverse microbiota was found in 
children of 1-5 years of age. Actinobacteria, Bacilli and Clostridium cluster IV retain 
the abundance characterized as child-like, while some other taxa already started to 
progression to adult-type assembly. The overall microbiota stability increased with age, 
which seems to be driven by the increasing stability of Bacteroidetes. In children, a 
???
common core of microbiota was identified, consisting of 18 to 25 abundant genus-level 
taxa, such as butyrate-producing bacteria. The microbiota core was shown to be 
developing toward an adult-type composition. In conclusion, we found that the 
intestinal microbiota in children is still developing, suggesting that the establishment 
adult-like profile may proceed even after the age of 5 years. The discordant 
development patterns observed with different taxa might reflect physiological 
development pattern in children (Table. 14).  
 
Table 14. Microbiota characteristics in healthy children at 1-5 years of age 
Microbiota features Characteristics 
Diversity Lower than in adults 
Stability Lower than in adults, but increasing 
Composition Difference bacterial taxa “mature” at different age 
Core microbiota Smaller core than in adults, but expanding 
Our results in study III suggest that intestinal microbiota and the host-microbe cross-
talk play a role in the CeD. No significant difference between CeD and HC was 
demonstrated in the overall microbiota composition as evaluated by its phylogeny or 
the potential immunomodulation capacity of microbiota as assessed by the estimated 
MAMP content. However, eight genus-like bacterial taxa, which separate CeD and HC 
may play a role in the disease by affecting the epithelial integrity. The involvement of 
impaired barrier function in CeD is further supported by the elevated expression of 
TLR2 and its positive correlation with tight junction protein in healthy individuals. 
Elevated expression levels of IL10, IFN-γ and CXCR6 were found in both treated and 
active CeD groups, suggesting that the Th1 responsiveness in CeD subjects may be 
attributable to the increased level of TLR9 signaling, even with adherence to a GFD.  
All our findings in healthy and CeD pediatric populations should be further 
investigated in larger cohorts in a more controlled environment before any conclusions 
can be generalized. Functional genomics approaches, such as metagenomics, 
transcriptomics and proteomics will become ever more important for investigating 
mechanisms involved in host-microbe interactions. These will require a more 
comprehensive understanding of the molecular mechanisms behind microbial 
symbiosis or dysbiosis for their human host. The specific microbial signatures of both 
symbiosis and dysbiosis could provide potential functional diagnostic and therapeutic 
biomarkers. These markers could then be applied for promoting the healthy/natural 
microbiota development, as well as for improving health in specific diseases via enteric 
microbiota modulation. For this purpose, bacteriotherapies, either involving probiotics 
(single bacterial species), cocktails (combination of bacterial species) or fecal 
microbiota transplantation (whole bacteria community) will be future cutting-edge 
research topics. There are experiments underway evaluating the potential beneficial 
role of Bifidobacterium spp. in various diseases ranging from neuropsychiatric 
disorders to obesity (Kalliomäki et al. 2008; Pärtty et al. 2015), as well as in CeD by 
combatting protecting gliadin-induced barrier dysfunctions (Cinova et al. 2011; 
Lindfors et al. 2008). Long-term studies that integrate microbial features, dietary data 
and pathological biomarkers from healthy status to pathological alterations in a large 
???
cohort of subjects with genetic predisposition will be critical for clarifying how 
microbial effects are intertwined with the onset of disease. 
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